PMCID,ID,Label,Selected Text,Start,End,Valid Prompt
1968524,11403,no significant difference,chemotherapy using CI treatment was as effective as bolus therapy.,3043,3110,True
1766476,11303,significantly decreased,"A multidisciplinary, multifactorial geriatric care program with systematic assessment and treatment of fall risk factors as well as active prevention, detection, and treatment of other postoperative complications resulted in fewer patients who fell, a lower total number of falls, and fewer injuries.",33730,34031,True
5852975,11973,significantly increase,"CASE was still significantly different in the SM groups only (p = 0.04),",32423,32512,True
5852975,11973,significantly increase,All subjects had a significant improvement in medication adherence that was augmented if they also had social media support.,48732,48856,True
3733607,11687,significantly increase,On WATER DAY the number of falls was statistically higher to FG than CG (5.4 ± 1.14 FG and 3.33 ± 1.37 CG p = 0.02) demonstrating the effect of the fatigue protocol on the concentration status of the athletes.,25049,25258,True
3936115,12276,significantly decreased,"Administration of MSB in asymptomatic patients with diverticulosis can lead to significant decrease of clinical diverticulitis incidence (p = 0.425). In addition, it can decrease the need for imaging studies associated with diverticulitis (p = 0.0229).",28417,28704,True
2699720,11983,no significant difference,"Over 12 months, there were no significant differences in total cholesterol, triglycerides, or calculated LDL between dietary groups.",32309,32441,True
4518420,12321,significantly decreased,Patients in Ksharasutra group experienced significantly (P = 0.001) less pain than fistulotomy patients.,14506,14628,True
4518420,12321,significantly decreased,"Early postoperative pain was observed in both group; and it was found to be less in Ksharasutra group,",18877,18979,True
5498709,12999,significantly decreased,"The total administered dosage of ephedrine was significantly lower in the M group (median 4.1mg vs. 17.1mg, p=0.001).",16477,16594,True
37407,11550,no significant difference,"In conclusion, we have shown that gastric residual volumes in the prone and supine position do not differ significantly.",19155,19275,True
3493722,11904,no significant difference,"In conclusion, the one week PPI+BMT regimen was as effective as the 2-week PPI+BMT regimen.",27279,27372,True
3580400,13327,no significant difference,Curcumin C3 Complex® was associated with lowered hematocrit and increased glucose levels that were clinically insignificant.,10398,10535,True
3661741,12268,significantly increase,satiety was increased with both SED and INT conditions (INT>EX and SED>EX; P<0.05).,4699,4782,True
5827475,12478,no significant difference,The ventilation scores and the fibreoptic gradings were similar with both I-Gel™ and PLMA in all the three different neck positions.,17652,17784,True
1550259,11672,no significant difference,"Based on our findings, the effect of gonioscopy on the mean K derived from Auto-Keratometry is insignificant, but the same cannot be said when relying on topographically derived Sim K.",24273,24457,True
1550259,11672,no significant difference,Reversible steepening of the central corneal surface is produced by the act of gonioscopy as measured by Sim K,5342,5452,True
1084341,11355,no significant difference,a ketamine serum concentration of 30 ng/ml did not result in a change in electrical pain threshold when administered alone,25733,25857,True
5861369,12574,significantly increase,"cortisol levels (cortisol 0, cortisol 60, peak cortisol and AUC cortisol) increased significantly during escitalopram vs placebo.",21107,21237,True
1134663,11877,no significant difference,"we found a significant shortening of the latency differences between the onset of the APB and deltoid muscle contraction during the course of the motor training as revealed by ANOVA for repeated measurements (significant influence of the factor ""training duration"", F(3.14,43.95) = 17.729, p < 0.001; Fig. 1A). Memantine did not affect this training effect, as shown by the non-significant influence of the factor ""drug"" (F(1,14) = 1.876, p = 0.192), and by the non-significant interaction between both factors (F(3.14,43.95) = 1.646, p = 0.191).",10980,11566,True
5807625,12627,no significant difference,"Despite our hypothesis on the effectiveness of the TiF4 varnish, results obtained at the first month of this study demonstrate that the differences between TiF4 and NaF did not reach significance, due to the slight changes in the visual analysis and in the fluorescence loss.",44210,44507,True
2699720,11985,no significant difference,Systolic blood pressure and diastolic blood pressure were similar between dietary groups at baseline and did not change over the 12-month period,32076,32220,True
5729494,12797,significantly decreased,"apoB levels remained low in the liraglutide treated group (apoB change: 0.03 ± 0.02 mmol/L, p = 0.4) in contrast to an increase in the control group (apoB change: 0.06 ± 0.07 mmol/L, p = 0.02).",9341,9660,True
1420296,11592,no significant difference,"There was no difference in total scores between intervention and control group students (13.4, 14.4, p = 0.12).",13846,13958,True
1794491,11622,significantly increase,"The magnitude of elevation in CCK concentration was greater in patients during the 2 kcal/minute infusion (AUC (0–180 min): 255 ± 34 versus 176 ± 22 pmol/l.min, P = 0.045), but not the 1 kcal/minute infusion (AUC (0–180 min): 110 ± 42 versus 140 ± 26 pmol/l.min, P = 0. 42), compared with healthy subjects.",26458,26821,True
3531427,11740,no significant difference,Iloprost inhalation did not affect 6-minute walking distance (p = 0.36; Table 3 ; Figure 2 ).,30035,30263,True
3698086,11914,significantly increase,"In DH+ TO lungs, the relative abundance of elastin-containing secondary crests was increased as compared to DH lungs (P = 0.01), above the level of SHAM lungs (P = 0.017).",55663,55868,True
3698086,11914,significantly increase,Finally SHAM lungs subjected to TO showed an increased in the relative abundance of elastin-secondary crests (P = 0.013).,56036,56175,True
1847837,11589,significantly increase,"With an individual patient change in ACQ score of 0.5 signifying a clinically relevant change in health status [24], 50% of subject improved on AKL1, 22% of subjects improved on placebo and 28% had similar health status changes on AKL and placebo.",27735,28021,True
4301658,12798,significantly decreased,"In the moxibustion group, the Birmingham IBS Symptom Scale and IBS QOL Scale scores significantly decreased, from 28.27 ± 6.64 to 9.00 ± 4.05 (P < 0.01) and 80.33 ± 8.49 to 48.27 ± 7.69 (P < 0.01), respectively, after treatment. In the control group, the Birmingham IBS Symptom Scale and IBS QOL Scale scores significantly decreased, from 27.38 ± 3.95 to 21.46 ± 4.31 (P < 0.01) and 80.54 ± 8.27 to 70.62 ± 7.42 (P < 0.01), respectively, after treatment. The decreases in the Birmingham IBS Symptom Scale and IBS QOL Scale scores in the moxibustion group was significantly greater than those in the control group (P < 0.01)",27412,28035,True
3691744,12212,significantly increase,"In all AZD3199 treatment groups, FEV1 measurements post-salbutamol inhalation increased by approximately 50 ml over the course of the study.",52712,52864,True
3691744,12212,significantly increase,"Numerically, but not statistically, larger increases in post-salbutamol FEV1 values were observed for the AZD3199 treatment arms than for the placebo and formoterol 9 μg treatment arms.",52864,53061,True
3672764,13144,no significant difference,"the trends in pain reduction among the three treatment groups were similar when pain was assessed using the Likert scale and the NRS; no significant differences were observed with rilonacept plus indomethacin relative to indomethacin monotherapy, but indomethacin monotherapy was significantly superior to rilonacept monotherapy at all time points (P < 0.05).",27914,28290,True
5834159,13281,no significant difference,"Although the Kaplan-Meier plot (Fig 2) suggested that linkage to care may have been faster in the PoC CD4 arm compared to the SoC arm, there was again no statistical evidence for an effect (p-value from log-rank test = 0.30; Fig 2).",48975,49312,True
5826979,12826,no significant difference,"At baseline, between the 3 groups there was no significant difference in numbers at the intention to act stage (FAQ, 53/104; LIST, 48/74; CONTROL, 37/60; χ24=8.2, P=.09).",35073,35300,True
529470,11421,significantly decreased,"We found significantly fewer early failures in the cautery study than in the fascial interposition group from the randomized controlled trial: 1.0% (4/389) versus 4.9% (20/410) (p = 0.0014 by the Fisher exact test). The adjusted odds ratio was 4.8 (95% CI, 1.6–14.3), indicating nearly a five-fold higher risk of early failure in the fascial interposition study than in the cautery study.",17244,17633,True
4364400,12750,no significant difference,"There was no significant difference in qualitative vascular enhancement between gadopentetate dimeglumine and gadoxetic acid, with the exception of higher scores for hepatic veins on gadopentetate dimeglumine-set (9.7 ± 1.6) vs. gadoxetic acid-set (7.3 ± 1.9, P < 0.005) for observer 2.",27992,28295,True
5836873,12335,no significant difference,There was no significant group difference between the intervention and control groups on the CES‐D or GAD‐7 or for self‐efficacy.,40339,40470,True
1914252,11467,significantly decreased,"A significant reduction in antibodies against oxidized LDL was seen in the aggressive (13.4%; P < 0.001) and the conventional (26.8%; P < 0.001) group, but there was no difference between groups (P = 0.25).",5171,5434,True
5511975,11689,significantly increase,Results showed that CD4 levels increased significantly after 90 days (p=0.001) in the intervention group who received IMOD in addition to the HAART regimen.,24828,24985,True
5511975,11689,significantly increase,"In this study, a slight increase was observed in CD4 in the control group who received the HAART regimen only; however, the mean difference was not significant (p=0.87).",25248,25419,True
4752899,13222,no significant difference,"There was also a difference between groups in the percent change in S. japonicum (epg) from screening to 22 weeks gestation, though this did not reach statistical significance (−53.11 versus 128.7; P = 0.054).",30752,30998,True
3728073,11875,significantly decreased,The fold change of HBP at day 7 versus day 0 in patients treated with simvastatin was significantly (p = 0.014) lower than in placebo-treated patients (Figure 3D).,17129,17329,True
3728073,11875,significantly decreased,The fold change of HBP at day 7 versus day 0 was expressed for patients who have received placebo or 80 mg simvastatin.,16124,16244,True
5759220,11880,significantly decreased,"treatment with liraglutide caused a significant reduction in PWV, AI, systolic blood pressure and central systolic blood pressure (p < 0.05, Tables 2 and 3) while these changes were not evident in patients treated with metformin (p > 0.05) after adjusting for HbA1c, weight, BMI and waist circumference. Thus, post treatment patients that received liraglutide had lower PWV, AI, systolic blood pressure and central systolic blood pressure than those on metformin (p < 0.05).",29818,30377,True
3744251,12435,no significant difference,"The present study revealed that there was statistically insignificance difference between the annual cost per-test of the study group and control group in pre-intervention (P=0.39) while, significant improved in average annual cost per-test was observed in post – intervention of study group (P=0.019), this result indicating that adoption of ISO 15189 largely affect the cost of test",23636,24054,True
1913056,11368,no significant difference,"Basal urinary recovery of L-rhamnose was not significantly affected by ingestion of indomethacin plus placebo, ATP or adenosine (Table 1).",25438,25621,True
5827033,11998,significantly decreased,"Time to first flatus in the TEA group was significantly shorter than in the control group (73.19 ± 15.61 vs 82.82 ± 20.25 h, P = 0.038)",19623,19792,True
4706730,12579,significantly decreased,"Duration of hospitalization in double dose group was significantly lower than that of the single dose group (11.55 vs. 14.76 d, P < 0.001).",29822,29961,True
4675066,13025,no significant difference,"The mean composite score of the children did not differ between the iodine and the placebo groups in cognitive (99.4 ± 12.2 versus 101.7 ± 8.2, mean difference (MD): −2.3; 95 % confidence interval (CI) −7.8, 3.2; P = 0.42), language (97.2 ± 12.2 versus 97.9 ± 11.5, MD −0.7; 95 % CI −7.0, 5.6; P = 0.83) or motor (93.9 ± 10.8 versus 92.4 ± 9.7, MD 1.4; 95 % CI −4.0, 6.9; P = 0.61) development (Table 2).",22949,23445,True
5739614,13019,no significant difference,Baseline serum CK-MB and cTnI levels were normal and not significantly different between the TMZ and control groups.,22021,22137,True
58836,11369,no significant difference,"Presenting cardiovascular risk as either an AR or NNT had no impact reducing cardiovascular risk at 12 month follow up, adjusted odds ratio 1.53 (95%CI 0.76 to 3.08). There was no difference between the two groups in systolic (adjusted difference 0.97 mmHg, 95%CI -2.34 mmHg to 4.29 mmHg) or diastolic (adjusted difference 0.70 mmHg, 95%CI -1.05 mmHg to 2.45 mmHg) blood pressure.",3871,4251,True
58836,11369,no significant difference,Cardiovascular risk increased in both groups during the 12 months of follow up,13244,13322,True
5752804,12078,no significant difference,The comparative incidence of nausea and vomiting and other side effects such as hypotension and bradycardia was not significant statistically except for the incidence of shivering in dexmedetomidine group (2%) as compared to PCM group (16%).,15584,15825,True
88884,11184,no significant difference,Smoking decreases the amount of air that gets into your lungs ........................	86.5	89.6	N.S.	90.2	N.S,24180,24405,True
2649924,12564,no significant difference,The types of patients examined in this study require treatment for their atrial fibrillation. Our study shows that both amiodarone and magnesium sulphate work safely and sufficiently rapidly for this purpose.,33979,34188,True
1550632,11531,significantly increase,The original program was more effective than the modified program in helping current smokers in the contemplation stage of change quit smoking and in helping former smokers avoid relapse.,38451,38639,True
5557991,11780,significantly decreased,"During local anesthesia administration, the children sedated with intranasal midazolam demonstrated significantly more movement (P=0.001) than those sedated with ketamine.",24291,24462,True
5557991,11780,significantly decreased,Ketamine (0.5mg/kg) led to fewer movements,5164,5206,True
3616744,13200,significantly increase,"During the randomized withdrawal phase, symptom relapse (defined as ≥ 50% increase in ADHD-RS-IV score and an increase in CGI-S rating ≥ 2, indicating deterioration of symptom control) was seen in 8.9% of subjects who continued on LDX, compared with 75% of subjects assigned a placebo (P < 0.0001) (Figure 4).",23170,23547,True
59610,11166,significantly decreased,"Interestingly, a statistically significant reduction in total mortality in patients treated with LMWHs was also found in this meta-analysis.",10723,10864,True
5852975,11969,significantly increase,Improved acceptance of illness	3.15 ± 0.51	3.65 ± 0.53	0.03,37884,37982,True
5852975,11969,significantly increase,"In addition, mean scores for all seven empowering outcomes were higher in the SM group vs. the control group",36454,36563,True
1852556,11564,significantly decreased,the present study showed a significant improvement in LDL-C occurred with the present number of subjects indicating that the effect of plant sterol ester is significant.,29027,29196,True
1852556,11564,significantly decreased,"There was no significant change in any of the measurements within the placebo phase (Table 1). Within the treatment phase, in comparison to day 7, LDL was significantly reduced at day 21(P < 0.05),",17095,17331,True
4748323,11772,significantly decreased,"the 16-week iStoppFalls exercise program reduced physiological fall risk as hypothesized and additional subgroup analyses revealed that intervention participants with better adherence also improved in postural sway, stepping reaction and executive function.",56520,56778,True
4469426,12399,no significant difference,"Biomarkers of inflammation, including plasma CRP, IL-6, and TNFα, were also not affected by either diet.",38618,38723,True
4745960,13209,significantly increase,"We report more complications in the EX-PRESS P-50 group. At 3, 6, and 12 months follow-up, the control group was found to be free of complications, whereas multiple complications were observed in the EX-PRESS P-50 group at 3 and 6 months follow-up.",4419,4667,True
3717762,11700,no significant difference,"AEs other than ocular were reported for 13.6% (41/301) of bimatoprost PF and 14.2% (42/295) of bimatoprost patients (p=0.828), with nasopharyngitis being the most common. Skin hyperpigmentation AEs, all of which were considered to be treatment-related, were reported for 1.0% (3/301) of bimatoprost PF and 0.7% (2/295) of bimatoprost patients.",36451,36794,True
5827033,12000,significantly increase,"Bowel sounds on day 2 in the TEA group were significantly greater than in the control group (2.30 ± 2.61/min vs 1.05 ± 1.26/min, P = 0.017).",42796,42971,True
4431716,12507,no significant difference,"A drop-out analysis showed that the rate in the study group was 2.2% (8/360) compared to 4.7% (17/360) in the controls (X2 = 3.36; RR = 0.47; 95% CI 0.21–1.08; z = 1.76, p = 0.07).",45408,45600,True
3658908,12032,significantly decreased,"The median baseline fecal calprotectin concentration increased significantly after treatment in both groups. However, when the calprotectin concentration before treatment was set to 1, the fold increase after treatment was significantly higher in Group O (1.0 ± 0.0 to 18.1 ± 37.1, p = 0.0002) than in Group I (1.0 ± 0.0 to 6.0 ± 11.1, p = 0.028) ( p<0.05, Figure 3).",30406,30813,True
3640960,13014,significantly increase,"At day 4, the filgrastim group had significantly higher HBP –concentrations when compared to placebo group 25.1 ng/ml [17.7-35.5 ng/ml] vs. 13.9 ng/ml [12.0-19.5 ng/ml], respectively (p < 0.05).",15783,15978,True
3626633,12467,no significant difference,"Lean mass (kg)
−0.4 ± 1.0
−0.5 ± 1.2
0.77
−0.8 ± 0.9
−1.2 ± 1.7
0.24
−1.1 ± 1.1
−1.4 ± 1.2
0.3",8104,8630,True
5490100,12155,significantly decreased,"From the discussion, we, therefore, conclude that after showing videos/images in Group I, the HAM-A scoring was extremely, significantly reduced and even if we compared the same Group I before PAC and 1 h before surgery, there was highly significant reduction in anxiety score.",19862,20139,True
1190172,13180,no significant difference,The results indicate that a hand-signed covering letter is unlikely to improve the response rate or time taken to respond to a postal survey when compared with a covering letter bearing a computer printed signature.,10333,10548,True
1949842,11438,no significant difference,"The overall probability of HIV infection or death among infants aged 12 mo of all women enrolled in this study was 11.7% (95% CI 7.5%–15.9%); the probability was 11.2% (95% CI 5.0%–17.4%) among infants born to HAART-treated women, and 12.1% (95% CI 6.4%–17.9%) among infants whose mothers received scARV for PMTCT only (log-rank test, p = 0.90) (Table 4).",38703,39129,True
5728271,12801,significantly increase,"significant improvement was found for efficacy (B=−6.72, 95% CI −8.15 to −5.28, p<0.001) and satisfaction (B=−4.48, 95% CI −6.27 to −2.69, p<0.001) for parents in the intervention group.",6501,6688,True
32174,11175,significantly decreased,"More PHR than control group patients felt ready to go home at the point of discharge (82% vs. 60%, p=0.14), but control group patients were more likely to have been instructed in how to cope at home (49% vs. 33%, p=0.11).",23969,24192,True
5722253,12175,no significant difference,"The surface roughening observed in composite samples after exposure to a common OTC dental whitening strip was not observed in such samples after exposure to a novel whitening strip formulation. Both strips caused similar levels and types of color change in composite materials, with minimal effects on dental porcelain.",24776,25096,True
5883519,12473,significantly decreased,"In this study, after 6 months of rhGH treatment, the serum ALT and AST were significantly decreased compared with the untreated control group.",38385,38528,True
1847683,11453,significantly decreased,A dosage of 6 grams concentrated β-glucan per day for six weeks produced significant reduction from baseline in total and LDL cholesterol. The reduction in LDL cholesterol was significantly greater than in the control group.,42270,42495,True
1847683,11453,significantly decreased,Treatment of oat β-glucan significantly lowered LDL cholesterol compared to control (p < 0.026).,26520,26617,True
3655222,11856,significantly decreased,"The need for additional uterotonics was significantly lower after carbetocin versus the subgroup oxytocin 5 IU (3.1 vs. 9.3 %, p = 0.0067),",20286,20442,True
3769981,12770,no significant difference,"Increases in 24-h urinary calcium excretion from baseline to last on-treatment assessment paralleled changes in serum calcium, with 19.73-mg (P = 0.003 versus placebo) and 26.12-mg increases (P < 0.001 versus placebo) for the paricalcitol 1- and 2-μg/day groups, respectively.",24834,25112,True
3376123,11867,no significant difference,At 12 weeks there was no significant difference between patients who recorded an rSO2<50% with respect to development of POCD.,37955,38081,True
5809706,12372,no significant difference,"The distribution of device sizes, ease of insertion, and number of insertion attempts were similar between groups.",14404,14519,True
5155184,12541,no significant difference,"There was no significant difference in heart rate, oxygen saturation level, or ECG changes between the two groups.",16613,16727,True
5561409,11820,significantly increase,"During REM sleep, alpha activity was significantly higher in nights with transdermal nicotine patch compared to nights with placebo patch also on the first NREM-REM cycle of the nights (t=−2.673, df=14, p<0.05)",19857,20068,True
1590049,11444,no significant difference,"The median (IQR) HTLV-I proviral load at baseline was 4.2 (2.6–7.5) copies per 100 PBMCs (mean (SD) 3.7 (0.4) log10/100,000 PBMCs). No significant change in proviral load was seen during the first 24 weeks of the study in the active arm compared with the placebo arm (mean difference (SE): 0.02 (0.17), p = 0.92) (Table 3) nor within the placebo arm comparing the first 24 weeks of placebo therapy with the second 24 weeks of active therapy (mean difference (SE): 0.12 (0.16), p = 0.50)",24352,24889,True
5843959,12601,no significant difference,The length of the need for nCPAP was not statistically different in both groups (P = 0.54).,22973,23082,True
3932837,11946,no significant difference,"Between groups, no significant differences of secondary clinical outcomes (PPD, RAL, and RGR) were found for any of the variables at 6 and 12 months (Table 2).",22940,23140,True
3932837,11946,no significant difference,"the NHA and EMD groups showed statistically significant reduction of PPD, increase in recession, and gain of attachment after 6 and 12 months (P < 0.001).",21799,21971,True
3669105,12597,no significant difference,"Improvement in LVEF was significant in both study arms at 6 and 12 months (p = 0.04), normalizing ventricular function in 9/16 evaluable patients. There was no statistical difference between study arms for treatment (p = 0.86) or for the interaction (p = 0.89).",54160,54422,True
5333470,13402,significantly decreased,Cumulative of meperidine supplementary doses at each time intervals after surgery was significantly lesser in the dexmedetomidine gourp than the control group (P = 0.002).,25917,26107,True
1914252,11463,significantly decreased,"Lipid levels decreased significantly in the aggressive treatment group (LDL-C reduction 20.8%; P < 0.001), whereas a slight increase was observed in the conventional group (LDL-C increase 3.7%; P = 0.037).",4928,5170,True
4696193,12413,no significant difference,There were no significant differences in the frequency and duration of these symptoms between the two study groups during the overall follow up.,17883,18027,True
1913056,11365,significantly increase,"Median L/R ratios after indomethacin ingestion with administration of ATP or adenosine remained significantly increased compared to the L/R ratio in the control condition (P < 0.01, Fig. 1).",23174,23407,True
3563445,12821,no significant difference,"When comparing the levels of HITChip signals between children from the placebo group and those who had received L. rhamnosus GG for their first 6 months of life, no statistically significant differences were observed at the age of 6 months.",36389,36646,True
5873829,13412,no significant difference,"The proportion of patients showing histological improvement by at least one Marsh grade was higher in GFD+P group, though the difference was not statistically significant.",21999,22171,True
5873829,13412,no significant difference,"The median improvement in the Marsh histological grade was higher by one grade in GFD+P group at six months. However, this difference was not seen at 12 months.",26233,26394,True
4771973,11993,no significant difference,"Change in mean carotid IMT did not differ between the metformin and placebo groups (mean between-group difference 0.012 mm (95% CI −0.003 to 0.026), p=0.11,",-1,-1,True
3701833,12743,significantly decreased,"Intragroup comparison of the PD and CAL at baseline, 12 weeks, and 24 weeks showed a statistically significant reduction in mean scores across all the groups with the differences being more significant from the baseline to 12 and 24 weeks (P<0.001). In the lycopene group, however, this reduction was significant (P=0.001) when the PD at the end of the 12th week was compared to the score at 24 weeks",20463,20901,True
4588424,12021,no significant difference,"Occurrence of lacunar infarction (Fig. 3C), cardioembolic infarction (Fig. 3D), and intracranial hemorrhage (Fig. 3E) was similar between the two groups, so was the occurrence of myocardial infarction, vascular accidents, death, and hospitalization (Table 2).",24675,25096,True
5706695,13311,significantly increase,"Regarding the effectiveness of the training methods, for the taught words at post-test1 both the definition group (b = 0.31, SE = 0.12, 95%CI [0.08, 0.53]) and the context group (b = 0.40, SE = 0.12, 95%CI [0.17, 0.62]) demonstrated significantly more knowledge about the taught words compared to the control group.",74418,74803,True
5706695,13311,significantly increase,At post-test 2 the definition group but not the context group demonstrated significantly more vocabulary knowledge than the control group,82047,82185,True
5884508,13406,significantly increase,"When adjusted for total tissue, the BPDS group had higher median 24-hour TEE as compared to the RYGB patients; 16.9 cal/min/kg (14.1 to 23.7) and 14.1 cal/min/kg (10.8 to 15.2), respectively (p = 0.015). The BPDS group also had a 24% higher total tissue normalised median of mean BMR; 14.3 cal/min/kg (11.0 to 17.5) and 11.5 cal/min/kg (7.2 to 13.5), respectively (p = 0.041).",58473,58849,True
4307364,12018,no significant difference,"After 8 weeks of treatment compared with the baseline values, reduction of monthly migraine frequency, and intensity demonstrated no statistically significant differences between the cinnarizine and topiramate groups (p> 0.05).",22843,23070,True
4307364,12018,no significant difference,"The reduction of monthly migraine frequency showed no significant differences for the cinnarizine group versus the topiramate group (p> 0.05), whereas monthly migraine intensity in the cinnarizine group reached a significant reduction in comparison to the topiramate group (p < 0.05).",23837,24121,True
5827302,13367,significantly decreased,"Independent samples t-test indicated significant between-group differences regarding BAI (Exercise Group=5.6±3.9 vs Control Group= 0.1±2.3, p = 0.02), showing that the exercise group had greater reductions in the scores (Fig. 4).",33022,33318,True
5827302,13367,significantly decreased,Post-hoc analysis revealed a significantly decreased score in BAI in the exercise group post-intervention,32786,32892,True
3769981,12771,significantly decreased,"In the active treatment groups, there was a dose-dependent reduction in iPTH, with a 26.9-pg/mL decrease in the 1-μg/day group (20.9% reduction; P < 0.001 versus placebo) and a 52.7-pg/mL reduction in the 2-μg/day group (48.9% reduction; P < 0.001 versus placebo).",25913,26178,True
3769981,12771,significantly decreased,"In placebo-treated patients, iPTH levels increased to 20.5 pg/mL at the end of treatment and 27.5 pg/mL at 60 days after treatment.",25782,25913,True
5789504,12486,significantly increase,The success rate was 100% (50/50) with C-Mac D-Blade versus 84% (42/50) with Macintosh laryngoscope.,18586,18687,True
5789504,12486,significantly increase,"In Group C, 98% (49/50) patients were intubated in first attempt and one patient required second attempt due to inadequate exposure, and in Group M, 86%(42/50, P = 0.031) were intubated in first attempt, 12% (6/50) required second attempt, and 4% (2/50) patients require third attempt.",18277,18579,True
3757803,11965,no significant difference,"The number of patients who developed severe EA (PAED >15) was significantly lower in group D and group P compared to group C. Compared to group D, group P showed no statistically significant difference.",14987,15189,True
3653866,12157,no significant difference,"The size of induration was not affected by phenol (Figure 4; Wilcoxon’s Signed Rank: P>0.05). Phenol (0.5%) preservation of C-Tb did not influence the immediate pain associated with the injection. Thus, 10/22 patients experienced no difference in VAS score between the left and the right arm. Among the remaining 12, five experienced less pain with the phenol preserved formulation.",27317,27752,True
3653866,12157,no significant difference,Phenol preservation did not affect the response. The specificity of C-Tb was 99.3% (95% CI 96–100%) regarding indurations ≥5 mm as a positive outcome. This was higher than the specificity of PPD (63% using a cut-off of 5 mm or 92% using a cut-off of 15 mm to adjust for non-specific BCG responses).,8032,8330,True
5771543,13182,no significant difference,"Week 8 CGI-I response rate for desvenlafaxine (68.7%) was also greater than placebo, although this comparison did not reach statistical significance (p = 0.343).",34492,34672,True
3718763,12024,significantly increase,"In the IPE 4 g/day group, baseline values were similar between all diabetes subgroups for all lipid, lipoprotein, and inflammatory parameters with the exception of hsCRP, which was numerically higher in the less-controlled diabetes subgroup than in the better-controlled diabetes subgroup.",18466,18755,True
3666902,12086,significantly increase,"After 6 weeks of treatment, patients in the olanzapine group had significantly greater weight gain than patients in the placebo group (2.12 [SE 0.21] kg vs. −0.36 [SE 0.29] kg; p < .001). Also, clinically significant weight gain (≥7% above baseline) occurred more commonly in the olanzapine group (20.2% vs. 1.9%; p = .001).",51786,52120,True
5789504,12485,significantly increase,"The percentage of Cormack–Lehane Grade 1 was much higher in the C-Mac D-Blade group as compared to Macintosh group [Table 3]. Eighty-six percent (43/50) patients had CL Grade 1 versus 30% (15/50, P < 0.001)",17400,17662,True
3751553,12185,no significant difference,"There was no significant increase in MRT during BL, BLF and Ramadan.",31363,31431,True
1969447,11618,no significant difference,relapse-free survival and overall survival were similar in the two treatment groups.,1808,1893,True
1969447,11618,no significant difference,"overall survival was somewhat greater in the placebo group than in the levamisole group, 68% vs 38% (P < 0.08).",1992,2103,True
3663731,12222,no significant difference,"Main analysis revealed that mean NCF scores were significantly lower in the intervention compared to the control group at 2-month follow-up (z=-2.89, p<0.01). The effect remained significant when NCF scores at baseline were carried forward for missing data at the 2-month follow-up as part of an intention to treat analysis (z=-2.83, p<0.01). These effects were not maintained at 6 months (Table 2).",37716,38160,True
3744465,12518,no significant difference,PSPC supplementation over a 17-d period did not alter established biomarkers for inflammation and oxidative stress but was linked to an enhanced gut-derived phenolic signature and ketogenesis in runners during recovery from 3-d heavy exertion.,8690,8933,True
3744465,12518,no significant difference,"The PSPC supplement used in this study contained a high dose of total phenolic compounds (2,136 mg GAE’s), the profiles of which were consistent with what is observed for green tea and fresh blueberries. The polyphenolic content was unchanged over the course of the study and in real terms is equivalent to the daily combined consumption of 3 whole cups of fresh blueberries (148 g/cup) and 1–1/3 cups of brewed green tea with its associated caffeine content (assuming 8 fl oz or 247 mls per cup).",59205,59702,True
2825665,12547,significantly decreased,Significantly less decline was observed on the Disability Assessment for Dementia scale among antibody responders than placebo-treated patients (p=0.015) after 4.6 years.,5653,5841,True
1713262,11484,significantly increase,"on day 14, the prevalence of asexual blood-stage Plasmodium-positive patients was significantly higher in the Cotrifazid group at 15% (11/72) than in the mefloquine group,",35623,35813,True
1713262,11484,significantly increase,Patients in the Cotrifazid group were more likely to develop P. falciparum gametocytaemia on day 14 than those in the mefloquine or quinine + SP groups,36927,37139,True
4354617,12385,no significant difference,"No statistically significant differences in changes in skeletal muscle mass were noted between training two versus three times a week in the present study. However, thrice-weekly training showed greater absolute increases compared with the twice-weekly condition (7.4% vs 4.4%, respectively) and the ESs were considerably larger when training three times a week as well (0.43 versus 0.21, respectively).",29567,29971,True
3483284,11872,significantly decreased,"Overall treatment main effect of supplementing 400 mg of ATP approached significance for both increased low peak torque (Figure 2B) and decreased torque fatigue (Figure 2C). Analysis (Least Squares Means) of the data by each set showed that ATP supplementation significantly increased low peak torque in set 2 (62.3 and 67.2 Nm in placebo- and ATP-supplemented participants, respectively (p < 0.01)).",21786,22260,True
3483284,11872,significantly decreased,"Set 3 torque fatigue also tended to be less with ATP-supplementation (60.5% and 57.8% in placebo- and ATP-supplemented participants, respectively (p < 0.10)).",22261,22419,True
1805771,11258,no significant difference,"Repeated measures ANOVA revealed no statistically significant difference between responses to Statement 4, ""This seems like a logical way to treat low back pain"", (F(2,58) = 0.707, p = 0.497) (Table 4). The partial eta squared (η2p) = 0.024.",28716,29018,True
1977297,11640,no significant difference,"Grouped according to customary size ranges of invasive cancers, the proportion of cases lymph node positive differed in those screen detected compared with controls, but the benefit in favour of screen detection was not constant.",2657,2886,True
1977297,11640,no significant difference,"In comparisons of cancers detected at prevalence and incidence screens, as a test of conformity with screening theory, no significant differences were apparent according to size and lymph node status, yet the characteristics of histological type of cancer discriminated significantly (P less than 0.05).",2887,3191,True
1550632,11530,significantly increase,"Among smokers in the precontemplation and preparation stages of change, there was no statistically significant difference in quit rates between programs; but the original program produced more quitters than the modified program among smokers in the contemplation stage",27918,28186,True
1065073,12919,significantly increase,"Analysis of the use of resuscitative measures as indicators of hemodynamic stability between the CMV and AV-ECMO groups revealed that significantly more lambs in the AV-ECMO group (including survivors and nonsurvivors) were resuscitated than in the CMV group (Table 4; P < 0.001, Fisher's exact test).",-1,-1,True
3532036,12511,significantly decreased,"These preliminary results show a one-year recurrence rate of 53.3% in the sorafenib group, which is significantly lower than that in the capecitabine group (86.6%, P < 0.05).",17639,17831,True
1705528,11516,no significant difference,25.4 versus 26.6% (P = NS)25.9 versus 24.8 versus 19.8% (P = NS),13029,13142,True
1705528,11516,no significant difference,NS = Not significant,13808,13828,True
5989624,13353,significantly increase,"Overall, patterns of lipid expression in the PPOS groups differed significantly from that of the short-term group, with most of the lipids showing upregulation with 10 mg PPOS (Figure 4A). Correlational analyses showed that there was a correlation between the selected variables and a high correlation between TAG-34: 1+NH4, TAG 58: 0+NH4, TAG 64: 3+NH4, TAG 64: 8+NH4 and DAG 38: 6+NH4 (Figure 4B).",21519,22033,True
5561409,11818,significantly increase,"Among sleep architecture measures, on the nights with nicotine patch, as compared to the nights with placebo patch, percentage of stage 1 was increased (15.5% vs. 10.9%, p<0.01) and percentage of stage REM was decreased (19.7% vs. 23.4%, p<0.05).",18465,18712,True
1783656,11613,significantly increase,"The LDL-C/HDL-C ratio was similarly increased by the two modified fats, with differences being about 15% greater than the POL diet (P < 0.001).",40627,40791,True
1783656,11613,significantly increase,"Fasting plasma glucose at the end of each test fat period (Table 4), revealed a significantly higher value after IE treatment than after either POL or PHSO (p < 0.001). Glucose also increased modestly after the PHSO diet relative to POL (p < 0.05). Individual fasting glucose data measured at entry and the end of each test fat period revealed that plasma glucose for every subject increased during the IE diet period (Fig 1).",40895,41403,True
32174,11173,significantly increase,"PHR group patients were significantly more afraid to ask questions of doctors than control group patients (21% vs. 4%, p=0.01).",23682,23809,True
5980306,11673,significantly increase,"In the units with straw and hay, the concentration of dust, endotoxin, and fungi (difference in logarithmic mean 1.92 (95%CI 1.71‐2.12); 2.86 (95%CI 2.59‐3.14); 1.75 (95%CI 1.13‐2.36)) were significantly higher compared to wood shavings and haylage.",6819,7068,True
1913555,11510,no significant difference,"In those patients who showed elevated GL-3 levels at baseline, a decrease of 2.56 (range −5.81 to 0.32, p = 0.009) after 12 months of agalsidase alfa treatment was seen. Similar results were seen in the agalsidase beta treated patients with a reduction of 1.84 (range −5.17 to −0.23, p = 0.012). This reduction of GL-3 was not different between the two treatment groups (p = 0.46). Twenty-four months follow up data (n = 15) showed a similar pattern.",83301,83753,True
56204,11498,no significant difference,There were no significant differences in the changes from baseline to study end between the ramipril groups and placebo.,17953,18074,True
56204,11498,no significant difference,"Changes over 6 months in duration of ≥ 1 mm ST-segment depression (STD), total ischaemic burden and maximum STD did not differ significantly between the treatment groups.",3218,3389,True
1810369,11227,significantly decreased,"There were five significant differences in which the control group scored higher at baseline than the intervention group (see Fig. 2): physical functioning (t = 2.98, P = 0.0083, df = 17), role limitations due to physical health (t = 4.21, P = 0.002, df = 28), vitality (t = 2.57, P = 0.0157, df = 28), social functioning (t = 2.59, P = 0.0151, df = 28) and the PCS (t = 3.24, P = 0.0031, df = 28).",17138,17743,True
4391192,13376,significantly decreased,Patients’ perceptions of nighttime noise were significantly lower in the experimental group than in the control group (P <0.05) (Table 2).Table 2,25503,25741,True
4980729,12053,significantly decreased,"Itchy eyes: During exposure in the pollen challenge chamber, score for itchy eyes increased slightly to about 0.5 and 0.3 in the placebo and pranlukast groups, respectively, with no significant difference between the groups. After the subjects left the chamber, the scores decreased in both groups. The score was significantly lower on the following afternoon in the pranlukast compared to the placebo group (0.154 vs. 0.436, p = 0.039).",21735,22189,True
1562427,11386,no significant difference,"After adjusting for score at baseline, age, sex and class attendance no significant differences between the exercise groups and controls were found, except for a decline in activity of at least moderate intensity in the resistance training group compared to the controls (adjusted difference: -12.2 min, 95% CI:-23.8;-0.7). Both the resistance training and the combined training group spent less time sitting compared to the control group after 6 months intervention. However, this difference was not statistically significant.",25266,25794,True
2699722,12606,no significant difference,There were no significant differences in A1C test rates among groups at 12 months postintervention.,32253,32353,True
5388694,11895,significantly increase,"Post hoc tests showed an increase in N2 amplitude from pretest to posttest for the cognitive training group (p < 0.01), but not for the two control groups (both ps > 0.34, see Figure 3).",45781,46063,True
3651308,11693,no significant difference,"Primary outcomes (IBS SS and IBS QOL) did not reach significance at 6 or 12 weeks, apart from IBS SSS being lower in the no-website group at 6 weeks - this disappeared by 12 weeks. Improved Enablement suggests patients with access to the Regul8 website felt better able to cope with their symptoms than the non-website group.",7100,7427,True
3714488,13273,significantly increase,"HCVR significantly increased after IH (Fig. 1) and tended to remain elevated (3 h after IH: P = 0.096; 6 h after IH: P = 0.105) thereafter. In contrast, an opposite trend could be observed immediately after the placebo exposure, which, however, was no more apparent at 3 h or 6 h after exposure.",21509,21876,True
59901,11223,significantly increase,"On follow-up, 7/14 questions previously rated as mis-specified in the Intervention Group had all dimensions described at follow-up (p = 0.008) while the Control Group did not show any changes from baseline. Participants in the Intervention Group were also more likely to explicitly describe patients (p = 0.028), comparisons (p = 0.014), and outcomes (p = 0.008).",4940,5371,True
5830087,12879,no significant difference,ORR was higher in the BTH1677 vs Control arm but the difference between groups was not statistically significant (60.4% vs 43.5%; P = .2096).,-1,-1,True
3685778,12070,significantly decreased,"The means (95% CI) of the umbilical artery (UA) pulsatility index (PI) and Systolic/Diastolic ratio(S/D) significantly decreased 2 hours after Sildenafil ingestion as compared to the placebo group [Table 2]. Mean umbilical artery systolic/diastolic ratio (UA S/D) significantly decreased in the Sildenafil group as compared to the the placebo group (0.60 [SD 0.40] [95% Cl 0.37-0.84], P=0.000). Mean umbilical artery pulsatility index (UA PI) significantly decreased in the Sildenafil group in comparison with the placebo group (0.12 [SD 0.15] [95% Cl 0.02-0.22], P=0.019.",15748,16393,True
1216327,11268,significantly increase,"Feedings of juices with different fructose/glucose ratio, with or without sorbitol and osmolality levels resulted in more fecal losses in the first 24 hours of diarrhea as compared with water feedings.",44202,44403,True
5732479,12171,no significant difference,"Viral load gradually returned to baseline levels in the following weeks, with no differences between the LPS and placebo pretreatment groups.",39605,39746,True
4177075,12661,significantly increase,"In the diabetes intervention group, the mean time spent on the website was 169 seconds (range 7 – 2989 seconds, SD 284). In the diabetes control group, the mean time spent on the PDF was 74 seconds (range 13 – 771, SD 81). The mean time spent on the website in the cholesterol intervention group was 194 seconds (range 12–2352 seconds, SD 315). In the cholesterol control group, the mean time spent on the PDF was 89 seconds (range 9 – 791, SD 98). Differences between the intervention and control groups were statistically significant (p < .000).",51787,52334,True
5791588,13229,significantly increase,"Frequency of IgG-positive FHA-specific MBC at day 30 post-vaccination was higher in the licensed TdaP vaccine, with the lowest observed responses in the investigational TdaP formulation containing the lower aP dose.",56824,57039,True
5835557,11791,no significant difference,". There was no difference in the AChR-ab titer between week 3 and week 12 (Table 2). Thus, the vaccination did not induce a clinically relevant AChR-ab boost (p < 0·0001 for testing non-inferiority).",33031,33289,True
5735483,12674,significantly increase,Addition of buprenorphine (60 μg) or dexmedetomidine (5 μg) to intrathecal bupivacaine for transurethral resection prolongs the time to the first analgesic request with comparable recovery profile.,5264,5461,True
1513406,13002,no significant difference,"The prevalence of parasitological failure by day 28 for the CQ group was 60.3%, compared to 17.6% for SP (odds ratio [OR], 0.106; 95% confidence interval [CI], 0.057–0.194; p < 0.001) and 13.9% for CQ/SP (OR versus CQ, 0.140; 95% CI, 0.078–0.250; p < 0.001). There was no difference between the SP and CQ/SP groups (OR, 1.324; 95% CI, 0.705–2.50).",6954,7338,True
5388694,11894,significantly increase,"The accuracy data yielded a significant main effect of Test Time (F(1,100) = 4.1, p < 0.05, ηp2 = 0.04) and a significant interaction of Test Time × Group (F(2,100) = 3.4, p < 0.05, ηp2 = 0.06). Bonferroni post hoc tests showed reduced error rates at posttest compared to pretest only in the cognitive training group (p < 0.01), but not in the two control groups (both ps > 0.84). Baseline accuracy at pretest was equivalent for the three groups (all ps > 0.99).",36137,37103,True
4218710,13004,no significant difference,No significant difference between the groups was noted with respect to the duration of surgery (P=0.06).,12267,12371,True
4218710,13004,no significant difference,"Three patients in group A (Fig. 1) and six in group B required a skin transplant for skin defects, but the rate of skin transplantation was not statistically different between the two groups (P=0.21; Table II).",12372,12689,True
28991,11261,significantly decreased,"In the crossover trial, peak inspiratory pressure was significantly lower using PRVC than with VC (20 cmH2O vs 24 cmH2O, P < 0.0001).",3377,3566,True
3744251,12437,significantly increase,"The compliance of study group and control group to ISO15189 was 49% for study group vs. 47% for control group with P value 0.48 in pre-intervention phase and 79 % for study group vs. 54% for control group with P value 0.00 in post intervention phase (Table 2). Simultaneously, the effect size (Cohen’s d) of the quality management activities in the pre intervention phase was moderate (0.00) and substantially different in the post-intervention phase which was large (0.99) Table 3.",17774,18392,True
5843437,12264,significantly increase,"The food supplementation infant’s mean weight and WLZ and WAZ were greater compared with the other group (0.81±0.29 gr and 0.55±0.33 gr, p=0.002), (0.36±0.36 and 0.02±0.52, p=0.003), (0.40±0.33 and 0.09±0.37, p=0.001). The recovery rate in the food supplemented group was significantly higher than the other group (68.4%, 31.6%, p=0.001). No adverse reactions were observed.",6323,6698,True
4504059,12376,no significant difference,HbA1c was also reduced significantly in both the groups at 12 weeks (P < 0.01). Intergroup comparison failed to demonstrate any statistical difference [Figures 1-3].,10623,10886,True
3669033,12804,no significant difference,"Mood state parameters showed mixed results (Figure 1), with no effect observed between supplementation groups for indices of Depression, Vigor, or Fatigue, whereas significant improvements were found in the TA group for Tension (−11%), Anger (−12%), and Confusion (−15%) compared to placebo. A non-significant trend (p = .083) was found for an improvement in overall well-being in the TA group (+3% in Global Mood State).",19885,20343,True
3714386,12875,significantly increase,"Sensory and motor block onset time values were found higher in group E and group N, besides significantly higher in group N than in group E (p<0.05).",13367,13517,True
3131514,12755,significantly decreased,"Lipid metabolism Lipolysis in the fasted state tended to be decreased by prednisolone treatment (p = 0.062), which was driven by the prednisolone 30 mg arm (p = 0.09) (Fig. 2a).",37726,37983,True
3686162,13153,no significant difference,"Similarly, survival analyses found no difference between the groups (χ20.49; p=0.5 by the log rank test, see figure 2).",31871,32056,True
1821028,11431,significantly decreased,"At the end of the six-week intervention period, it was fond that changes in triglyceride, total cholesterol, LDL-cholesterol, and HDL-cholesterol were significantly different from other groups. The mean total cholesterol concentration dropped in the garlic group by 26.82 mg/dl (P-value: .000.) Similarly, LDL-cholesterol was reduced in this group by 22.18 mg/dl (P-value: .000).",19925,20304,True
3666902,12082,significantly increase,Olanzapine treatment was superior to placebo in clinician-based assessments of global illness severity. Baseline-to-endpoint improvement was significantly greater for both the CGI-BP Depression scale (−1.4 [SE 0.11] vs. −0.9 [SE 0.16]; p = .008) and the CGI-BP Bipolar scale (−1.3 [SE 0.11] vs. −0.8 [SE 0.15]; p = .01).,25283,25605,True
3666902,12082,significantly increase,"They also had greater reductions in the following secondary measures: CGI- BP Depression (−1.41 vs. -0.89; p = .008),",5894,6012,True
4469426,12398,no significant difference,"The lipid profiles of the subjects, including TC, HDL-C, LDL-C, TG, and small density LDL-C, was unchanged during the study (Table 4). VLDL-C values were calculated from TG concentration, so changes in VLDL-C were identical to those in observed in TG. The building block of LDL and HDL, apoprotein-B100 and -AI, respectively, was not altered by either diet.",38219,38617,True
4757005,13063,significantly increase,The mean time off from work in group B was 9±2.35 days and in group A was 13.5±4. (P=0.0001).(Table-1),17594,17735,True
4757005,13063,significantly increase,"Also, the time off from work was longer for patients of group A than group B with statistical significant distribution and this came in concordance with published data of same interest (4, 13).",25061,25331,True
387830,12366,no significant difference,SF-36 scores are shown in Table 4. ANOVA showed no significant difference between SAMe and celecoxib on any measure.,-1,-1,True
387830,12366,no significant difference,"Both groups showed a significant improvement from baseline on the physical function, role physical, bodily pain, and general physical measures (ps ≤ 0.045). Neither group showed a significant change from baseline on the role emotional, mental health, social function, general health or general mental measures.",31331,31642,True
1863514,11305,no significant difference,"Vital, Physical, Haematological, Biochemical, and Endocrine Endpoints that Were Not Significantly Different between the Treatment and Placebo Groups (p > 0.05), and within the Normal Physiological Range for Humans",30380,30610,True
1863514,11305,no significant difference,"There were no significant differences in general adverse events or physical, vital, blood, and biomarker indices between the treatment and placebo groups (p > 0.05).",-1,-1,True
5801514,12496,no significant difference,"There were no main effects of MTJ (F1,96=0.07, P=.40) and of designated audience (F1,96=0.52, P=.24) regarding credibility.",38645,38859,True
5801514,12496,no significant difference,"However, the multivariate analysis yielded a significant interaction of MTJ and designated audience (F1,95=3.10, P=.04, ηp2=.031), with higher credibility judgments given for the condition that used high amounts of MTJ in professional forums (mean 3.05, SD 0.38) compared with the condition of using low amounts of MTJ in professional forums (mean 2.97, SD 0.47).",38859,39290,True
3606616,11814,no significant difference,"The median age of the infants when starting to latch-on and suckle regularly was 7.7 weeks, (Q1 = 3.7, Q3 = 10.7) in the experimental group vs. 7.1 weeks, (Q1 = 4.6, Q3 = 11.7) in the control group. This difference was not significant (p-value = 0.919).",62737,63034,True
5526285,12818,no significant difference,"The MI group missed a mean of 3.71 (SD = 4.12; range = 0 to 13) sessions, and the control group missed a mean of 4.07 (SD = 3.60; range = 0 to 14) sessions. These means did not differ between groups, t(102) = −.46, p = .65.",36467,36758,True
3691744,12214,significantly increase,"In a similar manner to FEV1, peak FVC was statistically significantly increased with all doses of AZD3199 compared with placebo, but no clear dose–response was observed (153–204 ml increase). Trough FVC was increased by 86–184 ml with AZD3199 compared with placebo, but the difference was not statistically significant for AZD3199 200 μg or 800 μg.",41120,41479,True
5755346,12894,significantly increase,A significant main effect for condition was observed for REE (p = 0.021) and diastolic blood pressure (p = 0.011) following ingestion of the MIPS. The supplement condition resulted in a greater number of BP repetitions to failure and total work completed during treadmill test (p = 0.039) compared to placebo (p = 0.037).,6578,6968,True
4694692,11942,no significant difference,"There were no significant changes from baseline in BNP, fibrinogen, or IL-6 with either FF/VI or TIO.",28319,28420,True
4650105,11887,no significant difference,"The OsteoACTIVE rehabilitation programme revealed no significant effect on quadriceps strength, BMD, dynamic balance, walking capacity or self-reported functional outcomes over the 1-year follow-up.",5908,6106,True
2699720,11986,no significant difference,"our study demonstrates that among overweight patients with type 2 diabetes, there was no significant difference in the weight or A1C change in participants after a low-carbohydrate compared with a low-fat diet for 12 months.",47160,47385,True
5809703,11676,significantly increase,"The dose and incidence of additional propofol were significantly higher in Group P1.5 (median [range]; 20 [0–50], 51%) than in Group P2 and Group P2.5 (0 [0–0], 0% in Group P2.0 and 0 [0–50], 8.5% in Group P2.5, all P < 0.001).",15432,15660,True
5891027,11785,no significant difference,"Although phenylephrine infusion significantly increased mean arterial pressure (P < 0.001), arterial partial pressure of oxygen did not differ between the two timepoints (P = 0.19).",11629,11848,True
3665020,11840,significantly decreased,Lactate dehydrogenase significantly decreased in group 2 (P = 0.02).,17641,17728,True
3665020,11840,significantly decreased,"The subjects were randomized using the permuted block size of 4, by another person, to one of the four groups: A: Vitamin C (250 mg/day), B: Vitamin E (400 IU), C: Vitamin C + vitamin E, and control (placebo).",12764,12974,True
3698202,12713,no significant difference,"There was a significant time effect for body fat (p < 0.05), which decreased in both conditions, 17.8 ± 6.0 to 16.6 ± 4.8 to 15.6 ± 4.9 kg in the rice protein condition and 16.3 ± 5.1 to 15.7 ± 4.8 to 15.6 ± 4.9 kg in the whey protein condition, from pre to post training, with no differences between conditions (no condition X time effect).",27137,27478,True
3640933,12527,no significant difference,"There was no significant difference between groups in intention to smoke in the next year at baseline (p = 0.12) (Table 2). Following the intervention, there were no significant main effects on intention to smoke in next year for either the health-based program (OR = 1.1, 95% CI = 0.3–3.4, p = 0.91) or the Islamic-based program (OR = 1.0, 95% CI = 0.3–3.1, p = 0.95) (Table 3).",52294,52769,True
5758845,13249,no significant difference,"In between-group analysis, the change of ACTH, cortisol, ghrelin, IL-6, ESR, and CRP between baseline and the end of study did not show statistically significant difference (Table 3). In within-group analysis, all clinical laboratory tests did not show significant difference.",20377,20694,True
3661377,12395,no significant difference,"Week 16 mean changes from baseline in PCS scores were numerically greater with apremilast 10, 20, and 30 mg BID than placebo but were neither statistically significantly nor clinically meaningful.",29957,30153,True
4712164,11805,no significant difference,Fortunately there were no significant flow induced changes among all groups (Fig. 1) concerning PRA (450.93±614.10 vs. 394.61±954.64 vs. 629.51±1116.46 pg/mL; P>0.05).,16498,16719,True
4301654,13134,no significant difference,"Patient satisfaction was rated better in ESD groups 1 and 2 at 3 months (1.32 and 1.49) compared to the control group (1.71), though not significantly (p = 0.115).",31685,31849,True
5976949,12884,significantly decreased,"ANGPTL4 expression was downregulated in the HUVECs derived from GDM patients compared to control group (23.11 ± 5.71, 21.47 ± 5.64, and 98.33 ± 0.92, respectively, for GDM1, GDM2, and control groups; p < 0.001 for comparison among the 3 groups) while no difference between GDM1 and GDM2 groups was observed (Figure 1(a)).",23411,23791,True
5838794,12269,significantly increase,"Finally, treated participants who had overweight lost more weight than treated participants with obesity at 3 months (F(1,124) = 6.25; P = 0.01) and at 6 months (F(1,124) = 6.27; P = 0.01).",33865,34122,True
1805771,11260,significantly increase,"Post hoc analysis identified significant differences in responses between HVLA and LT (p = 0.025) with a mean difference of -0.367 out of a maximum of 4. Participants responded more positively to the statement ""I believe this treatment would allow me to get better quicker"" for the HVLA treatment.",23787,24085,True
5498678,11764,significantly increase,"The responder rate on the side treated with CPM-26 (56%) was slightly higher than the responder rate on the side treated with VYC-20 (47%) at M3. Statistical analysis confirmed that the responder rate of CPM-26 was significantly non-inferior to VYC-20 (difference of responder rate: 0.09, one-sided 95% CI: [−0.07, 1]).",17052,17371,True
3658914,13350,significantly increase,"In the placebo group, HbA1c levels were increased in 11 patients (69%) after the treatment; levels were higher but not significant than those in the TGD-treated group (14 [39%]; p = 0.07).",23350,23539,True
4752985,13038,significantly increase,The result of the post hoc test (with least significant difference) shows difference of mean OHI scores between each of the two time intervals to be highly significant (p < 0.001) in both intervention and control groups except between baseline and 3 months scores in control group (p = 0172) (Table 5).,19310,19690,True
4752985,13038,significantly increase,"Similarly, difference of mean GI scores between each of the two time intervals was highly significant (p < 0.001) in both intervention and control groups except between 2 months and 6 months (p = 0.06) in the intervention group and between baseline and 3 months (p = 0.271) which was not statistically significant (Table 7).",19690,20110,True
3932837,11947,no significant difference,"Compared to the baseline data, the NHA and EMD groups showed statistically significant reduction of PPD, increase in recession, and gain of attachment after 6 and 12 months (P < 0.001). Both treatment modalities led to significant bone fill measured by bone sounding after 6 and 12 months compared to baseline.",21768,22096,True
4644316,12349,significantly decreased,"The results suggested that the mean anxiety of the experimental group declined by about 5.72 in the period between pretest and posttest, while this reduction in the control group was only 4.93.",24821,25015,True
4644316,12349,significantly decreased,"Thus, the conversational hypnosis intervention was effective in reducing the anxiety of the patients undergoing endoscopy (Table 3).",25260,25437,True
5217661,12725,significantly decreased,FMS/RSV combination treatment had greater efficacy in reducing siSBP from baseline after 8 weeks of treatment compared to that reported for RSV alone treatment (p < 0.001).,37774,37964,True
5217661,12725,significantly decreased,"Likewise, the reduction in siDBP from baseline after 8 weeks of treatment was significantly larger in the FMS/RSV treatment group compared to that in the RSV alone treatment group (p < 0.001).",38083,38292,True
5217661,12725,significantly increase,FMS/RSV combination treatment had greater efficacy in reducing siSBP from baseline after 8 weeks of treatment compared to that reported for RSV alone treatment (p < 0.001).,37774,37964,True
5217661,12725,significantly increase,"Likewise, the reduction in siDBP from baseline after 8 weeks of treatment was significantly larger in the FMS/RSV treatment group compared to that in the RSV alone treatment group (p < 0.001).",38083,38293,True
3717762,11702,no significant difference,Bimatoprost PF was equivalent to bimatoprost in average eye IOP at all follow-up time points in the ITT population.,32040,32156,True
3717762,11702,no significant difference,There were no statistically or clinically significant between-group differences in the ITT population (figure 2).,32289,32461,True
5827422,12838,significantly increase,"At post-test (Table 7), significant benefits of intervention were found for the number of positive and negative teacher interactions to the whole class (positive: ES = 3.35; negative: ES = −1.29) and the number of positive and negative teacher interactions to the high-risk children (positive: ES = 0.83; negative: ES = −0.50). Furthermore, teachers in intervention classrooms were rated as being more warm (ES = 2.03) and providing more opportunities for children to work together (ES = 5.72).",67167,67703,True
4138365,12939,no significant difference,"In crude analysis, there was a significant difference in fuel source between the two groups, but this was no longer significant after adjustment for other household characteristics (P = 0.33).",35056,35266,True
4590707,13138,no significant difference,"Heart rate and blood pressure did not differ between groups at baseline. Compared with placebo, melatonin caused a non-significantly decrease in systolic (5 mmHg, p = 0.12) and diastolic (2 mmHg, p = 0.40) blood pressure (Fig. 1). Heart rate did not change in response to treatment (data not shown).Fig. 1",33852,34252,True
5840243,13268,no significant difference,"The total number of patients who reported at least one DAS at follow-up was 56 (72%) in the IG and 51 (76%) in the CG. The IG was 15% less likely to report at least one DAS at follow-up; however, this difference was not statistically significant [odds ratio (OR) 0.85; 95% CI 0.38–1.88] (Table 2).",38495,38833,True
1794452,11329,significantly decreased,"A significant reduction in number of infections was observed in the supplemented patients, which decreased from 3.5 ± 1.2 to 2.0 ± 1.0 episodes per patient in placebo group (p < 0.001). This was related to a reduction of nosocomial pneumonia, which occurred in 16 (80%) patients versus seven (33%) patients, respectively (p < 0.001), and of ventilator-associated pneumonia from 13 to six episodes, respectively (p = 0.023).",6047,6527,True
4796457,12589,significantly increase,"In the present study, there was no significant difference between two experimental and control groups before the treatment in self-esteem scores. But after the treatment, self-esteem average scores of studied unit indicated a significant statistical difference in experimental group. In other words, the training sessions improved the score of self-esteem in the experimental group (P<0.001) versus control group (P = 0.08).",31271,31695,True
1904445,11648,no significant difference,"Analyses of data measuring the impact of the active strategy shows that there was no effect either on the metabolic control indicator (OR 1,06 [0,76–1,46]), or on macrovascular complications assessment tests (OR 1,07 [0,80–1,43]) or on microvascular complications assessment tests (OR 1,4 [0,91–2,16]).",37909,38211,True
4511434,13037,no significant difference,There were no absolute differences between groups in calories ordered from L1 to L2.,5220,5305,True
4511434,13037,no significant difference,All study groups decreased the number of calories ordered from Lunch 1 to Lunch 2 (Table 2).,20859,20993,True
4722945,11710,no significant difference,"Initially, glucagon concentrations after intranasal administration were lower than concentrations after intramuscular with the mean ± SD peak 3,155 ± 1,956 and 3,672 ± 1,726 pg/mL (P = 0.003) and median (minimum, maximum) time to peak 20 min (10, 90) and 15 min (5, 60) (P < 0.001), respectively, but were not different after 20 min (Fig. 1B).",34178,34612,True
5850145,12388,significantly decreased,"Importantly, hAPC therapy reduced interstitial fibrosis in the infarct border zone (−19% compared with the vehicle, P<0.01, Figure 3D and 3E), whereas the infarct scar was unaffected.",93304,93612,True
3747867,13378,significantly increase,"There was a significant A0–A12 treatment group effect, indicating that patients in CAPS had more improvement in medication adherence than those in CASM (P = 0.02) and Leap Ahead (P = 0.006). Patients who were female and who were nonwhite and those with poor baseline medication adherence showed the largest improvements.",28305,28659,True
4720464,13335,significantly decreased,The incidence of postoperative complications was significantly lower after consumption of coffee (p <0.05).,5358,5465,True
1915612,11320,no significant difference,"There were no significant differences between the two treatment groups in mean number of neck pain days, mean number of neck pain hours per day, mean number of days on which medication was taken, and mean number of tablets taken per day pre- and post-treatment (Table 3).",17077,17390,True
4138365,12940,no significant difference,"Reported diarrhoea was more common among trial children, although this difference was not significant after adjusting for other parental and household factors (P = 0.26).",36042,36229,True
4511433,12772,significantly decreased,In the dyslipidemia study LDL cholesterol was reduced by 7.4 % (p = 0.044),5813,5904,True
5801240,12224,significantly decreased,The incidence of symptomatic hypoglycemia was lower in the ertugliflozin groups compared with the glimepiride group,42479,42595,True
5117008,11815,significantly decreased,"By using analysis of variance (one-way ANOVA) did the primary outcome measure, mean VO2 peak, decrease significantly within groups from baseline to postintervention (12 weeks) in breast cancer groups (high, low and control).",45052,45288,True
1913555,11506,no significant difference,"There was no difference in median cardiac mass between the two groups at baseline (agalsidase alfa: 288 g, range 177 to 479, agalsidase beta: 316 g, range 213 to 517, p = 0.48). At 12 months, no significant reduction in cardiac mass was seen in both groups. Median change was −11% (−23 g, range −167 to 136 g, p = 0.51) following agalsidase alfa treatment and −15% (−46 g, range −226 to 131 g, p = 0.17) after 12 months of agalsidase beta treatment.",77170,77620,True
539050,11521,no significant difference,"An intent-to-treat analysis of the time to viral rebound (>5,000 copies/ml) in the open-ended interruption showed no difference between groups (continuous therapy/single TI, median = 4 [1–8] wk, n = 21; repeated TI, median = 5 [4–8] wk, n = 21; p = 0.36).",27252,27770,True
1783667,11502,no significant difference,"Chronic Illness Resources Survey
UC	2.77 (.55)	2.77 (.59)	2.77 (.60)	2.78 (.58)	5.76*	1.47
MLP	2.69 (.58)	2.92 (.65)	2.84 (.52)	2.80 (.56)",48036,48444,True
1569640,11426,significantly decreased,"The postprandial glucose AUC0−4 h, adjusted for pre-meal values, was significantly decreased after 24 weeks of treatment in the nateglinide group (−2.20 mmolh/l; P < 0.001) but the decrease in the gliclazide group (−0.61 mmolh/l) was not significant; the difference between the changes from baseline did not reach significance (P = 0.054).",23511,23899,True
3525027,12553,no significant difference,"our results showed that infusing three different dosage of NTG (50, 100, and 150 μg/min) had no significant effect on ABG tensions in patients underwent on-pump CABG surgery.",5739,5913,True
1488900,11477,significantly increase,Overall asthma symptoms improved in the azithromycin group (+0.55) and worsened in the placebo group (−0.13).,26781,26891,True
1974799,11288,significantly decreased,"Median time to PR was statistically shorter for rizatriptan (45 min) than other oral triptans (52 min, p < 0.0001).",31879,31995,True
3493722,11905,no significant difference,There was no statistically significant difference in side effects between the two groups (Table 3).,20255,20393,True
3493722,11905,no significant difference,"The prevalence of side effects was not significantly increased with treatment duration. In both groups, most patients tolerated well the side effects and continued medication with encouragement from the physician, even when the side effects were rather serious.",20483,20745,True
5985865,12690,significantly increase,"Regarding the pain scores, the greatest percentage of change was also noted in the combined group, whereas the least percentage of change was recorded in the ozone group.",36245,36415,True
5737852,11698,no significant difference,"ΔMAXDia showed higher values in women (18.54 mmHg; 95%CI [15.41, 21.67], maximum 33 mmHg) than in men (10.06 mmHg; 95%CI [7.40, 12.72], maximum 19 mmHg) in the ketamine group (Bonferroni-corrected F1,40=17.403, P<.001, partial η2=0.303). There was no difference in the placebo group.",36201,36537,True
1940326,11634,no significant difference,"All adverse events resolved without sequelae, and there were no deaths in either group.",24051,24139,True
1940326,11634,no significant difference,"23 events occurred among the 189 children in the FFM ME-TRAP group, and 26 among the 194 children in the control group. In the full 18 months of monitoring, there were 63 events in the FFM ME-TRAP group and 60 in the control group (HR = 1.2, CI 0.84-1.73, p = 0.35). There was no evidence that the HR changed over the 18 months (test for interaction between time and vaccination p = 0.11).",7158,7547,True
4980729,12054,no significant difference,"Watery eyes: During and after exposure in the pollen challenge chamber, score for water eyes was ≤ 0.2 in both groups, indicating that this symptom was very mild or absent.",22196,22368,True
3686216,13241,significantly increase,"However, compared with home access to traditional electronic games, removal of all electronic games resulted in a significant increase in MVPA (mean 3.8 min/day, 95% CI 1.5 to 6.1) and a decrease in sedentary time (4.7 min/day, 0.0 to 9.5) in the after-school period.",6159,6427,True
4917592,12326,significantly increase,"A greater proportion of subjects treated with esomeprazole 20 mg experienced complete resolution of sleep disturbance due to heartburn or other reflux symptoms over 14 days of treatment compared with placebo, regardless of the frequency of sleep disturbance during the run-in period (Fig. 1).",25391,25722,True
5830079,12026,no significant difference,"Parenteral nutrition associated cholestasis was 11 of 110 (10.1%) in the intervention and 18 of 113 (15.9%) in the control group (P = .20). Multivariable analyses showed no statistically significant difference in the intention to treat (aOR 0.428, 95% CI 0.155-1.187; P = .10) or per protocol population (aOR 0.457, 95% CI 0.155-1.347; P = .16).",5158,5555,True
3354371,12063,no significant difference,"Awakening time (spontaneous eye opening) and recovery time (when patient was able to answer simple questions such as name, age, date of birth, time, and place) were statistically insignificant in both groups [Table 4].",10926,11183,True
4469426,12396,significantly increase,"Compared to the CON diet, the ALM diet increased the post-intervention value of plasma α-tocopherol by 10.2 % (P = 0.0065) and decreased γ-tocopherol by 16.5 % (P = 0.047).Table 2",26016,26258,True
3872586,12550,significantly decreased,"The specimen retrieval time was significantly shorter in the transumbilical group than in the transabdominal group (43.5 ± 14.5 s vs. 69.4 ± 20.5 s, P < 0.001).",14544,14721,True
1847683,11456,no significant difference,"Triglycerides increased 0.09 ± 0.1 mmol/L (mean ± SEM) in the treatment group, but this change was not significantly different than 0. Triglycerides fell 0.2 ± 0.1 mmol/L (mean ± SEM) in the placebo group. The triglyceride change between the treatment and control group was significantly different (p = 0.030).",26716,27026,True
1847683,11456,no significant difference,Triglycerides were reduced in the control group but not the oat β-glucan group.,27222,27301,True
5732440,12787,significantly decreased,"Control group didn’t decrease their BMI values from pre to post-test, Wilks’ ʎ = .999; F(1,53) = 0.08; p = .782; η p 2 = .001; observed power = .059. In reverse, experimental group dropped significantly their BMI from pre to post-test, although with a less effect size, Wilks’ ʎ = .900; F(1,59) = 6.57; p = .013; η p 2 = .100; observed power = .713.Fig. 4",35402,36028,True
5313491,12146,significantly decreased,"The ICU length of stay was significantly shorter in the GDFR group (3 days [1–5] vs. 6 days [3–11], p = 0.001) (Fig. 1).",23479,23656,True
65683,11645,significantly increase,"Mean of daily steps was significantly higher in the exercise group from about 6,800 to over 8,500 steps (P < 0.01). In the control group, the number of daily steps ranged from 5,700 to 6,800 steps throughout the follow-up period.",4393,4639,True
1968524,11404,significantly decreased,There was significantly less nausea (P = 0.037) but more mucositis (P = 0.01) in the CI arm.,2943,3035,True
5986495,13205,no significant difference,No difference in hunger ratings was found between WAT and NNS (t17 = 0.28; p = ns).,41338,41453,True
116601,12105,no significant difference,"Following the enzyme replacement trial, no significant change in the global CBF was found at the 20-minutes post-acetazolamide time point in the ERT group compared to the placebo group, however, the resting global CBF in the ERT group was significantly decreased (p = 0.026).",22760,23036,True
5873829,13411,no significant difference,"No significant differences were detected in clinical recovery at eight weeks; none of the patients became seronegative at eight weeks, six months, or 12 months.",5906,6067,True
3961245,12983,significantly increase,The STRE group was more effective to strength gain for all muscles and pain control after 4 and 16 weeks (p<0.05). The FLEX group showed higher improvements in anxiety (p<0.05).,7169,7347,True
4947120,12242,no significant difference,"SCCQ-impossible and SCCQ-rewarding scores, measured at the end of treatment, failed to significantly predict MGHHS-scores at 3 months follow-up, F(2, 41) = 0.84, p = .44, at 12 months follow-up, F(2, 33) = 0.13, p = .88, or at 24 months follow-up, F(2, 22) = 1.58, p = .23.",37799,38175,True
4947120,12242,no significant difference,"Also, there were no significant findings when Condition was added as an independent variable, or when regression analyses were carried out for CT and BT separately.",38355,38520,True
5773985,13175,no significant difference,"However, the mean volume of bupivacaine solution including the amount needed for infiltration/reanesthesia was slightly higher (4.15 ± 0.52 ml) than the mean volume of buprenorphine combination with bupivacaine solution (4.12 ± 0.60 ml). The difference in the mean volume of both the solutions used was found to be statistically nonsignificant (P = 0.84).",15034,15406,True
5483485,12897,no significant difference,"40 (59%) children in the brief guided parent-delivered CBT group versus 47 (69%) children in the solution-focused brief therapy group had an improvement of much or very much in CGI-I score at the assessment after treatment, and 45 (66%) versus 49 (72%) children had an improvement at the 6 month follow-up assessment (table 2), with no significant differences between groups across both timepoints (relative risk 1·01, 95% CI 0·86–1·19; p=0·95; table 3).Table 2",39609,40199,True
5651290,12991,no significant difference,"the OR for improving by at least one category after the intervention was 1.4 (0.9–2.0, p = 0.10). This OR was corrected for the time since diagnosis, for remembering at least 50% of the DSMS, and for the country’s routine programme. Testing for interactions between these variables did not improve the predictive value of the model; thus, interactions were ignored. Moreover, we did not observe a cluster effect at educator level (webannex, Table 4).",38060,38551,True
5006415,12099,no significant difference,"the median (IQR) time to completion of the tasks in series was 125 (112 – 158) seconds and in parallel 122 (108 – 158) seconds, p = 0.92 (Additional file 1: Figure S2).",21915,22143,True
1693922,13234,significantly increase,"Although in both groups physical functioning improved and pain decreased but only in the TCF group statistically and clinically significant improvement was observed for global QOL (P = 0.001), social (P = 0.03) and emotional functioning (P = 0.004), pain (P = 0.03) and sleep difficulties (P = 0.02).",11209,11510,True
5001793,13304,significantly decreased,"Pain intensity in the PACU and morphine consumption was not significantly different between the TAP and ILI+IHG groups; however, they were significantly decreased when compared with the control group (Table 2).",27554,27818,True
1403758,12921,significantly decreased,There was some evidence that averaged over fenoterol dose and genotype terbutaline decreases FEV1 compared to placebo (P = 0.027) by an estimated 1.58 (SE 0.68) percent points.,31003,31191,True
3558408,12612,significantly increase,"The C:V ratio of 3:1 gave both higher TI and VT than the ratio of 9:3, giving a significantly higher minute volume (Mv) in ml per kg with 3:1 compressions to ventilations: 191(183–199) (median (IQR)) than in the 9:3 group: 140 (134–144) (p<0.001).",22101,22371,True
29022,11534,no significant difference,"After 20 min of ventilation the mean relative humidity of the inspiration gas was still lower in patients in group B (92.8%) compared with patients in group A (96.8%), group C (97.4%), and group D (98.6%).",23545,23758,True
29022,11534,no significant difference,After 2 h of ventilation patients in all four groups showed almost equivalent mean values (98 ± 0.4%). All measurements taken from this point until the end of the 100-h study protocol showed no more significant changes compared to the values measured after 2 h.,23765,24038,True
5762815,12959,significantly increase,A significantly higher proportion of home deliveries were attended by LHWs in the intervention clusters than in the control clusters (14% vs 1%; p<0·0001;,44912,45084,True
5038098,11955,no significant difference,"In the present study, both treatment regimens were well tolerated. Most common adverse effects noted in both groups were cheilitis (Group A, 97.46% and Group B, 95.69%) and dry skin (Group A, -16.9% and Group B, 10.3%).",23191,23410,True
5799931,11884,significantly decreased,"The odds of clinical pregnancy per patient were higher in Group B (OR = 0.56; CI [0.27–1.24]), with a trend toward better clinical pregnancy in Group B than in Group A [Table 3].",27140,27357,True
1794452,11328,significantly decreased,"All patients presented at least one episode of infection (Table 4). However, the number of infectious complications was lower in the supplemented group, this decrease being due to a lower number of nosocomial pneumonias (a mean of 0.33 episodes per patient in the supplemented group versus 1.55 episodes per patient in the placebo group, p < 0.001; Table 4).",17181,17637,True
5614421,12426,no significant difference,"The risk of respiratory distress syndrome was similar in both study groups, 10.5% (42/402) in the progesterone group and 10.6% (41/388) in the placebo group (adjusted RR 0.98, 95% CI 0.64–1.49, p = 0.912), as was the severity of any neonatal respiratory disease (adjusted treatment effect 1.02 [95% CI 0.69–1.53, p = 0.905]) (Table 2).",51910,52333,True
5819580,12935,significantly increase,"Both doses of meloxicam IV also produced significantly greater pain reductions than placebo at other post-dose intervals (ie, in SPID6, SPID12, SPID24, SPID12–24, SPID12–48, and SPID24–48 values) according to W2LOCF and LOCF analysis methods (P≤0.05; Table 4).",26994,27354,True
1852321,11666,no significant difference,Painful defecation and the presence of abdominal or rectal mass were not significantly different between the periods on NF and SF.,24969,25099,True
2367663,13284,no significant difference,"Overall, however, there was no significant difference in decrease of mean azinphos-methyl concentrations between the intervention and control communities after adjusting for year, p = 0.16. When examining phosmet, its mean residue concentrations increased significantly in both intervention and control communities in year 4 compared with year 1; in addition, there was a marginally significant difference between intervention and control communities after adjusting for year, p = 0.07, with intervention communities having higher mean concentrations of phosmet.",40851,41451,True
1914073,11241,no significant difference,"Both groups evidenced a decrease of anxiety and depressive symptoms according to the HADS with a trend for a stronger effect in the paroxetine group. However, no statistically significant difference between paroxetine- and placebo-treated participants was detected at any time point (Table 3).",27328,27660,True
1434781,13382,no significant difference,The mean size of the anterior capsulorhexis in group 1 and 2 was 5.9 ± 1.74 mm and 5.8 ± 0.92 mm respectively (p = 0.072). The mean size of the posterior capsulorhexis was 4.6 ± 1.77 mm and 4.0 ± 0.93 mm in the group 1 and 2 respectively (p = 0.04) (Table 1).,11255,11553,True
1977297,11638,significantly increase,"The cancers detected by screening were predominantly 'early stage', with 16% noninvasive (PTIS) and 42% invasive stage I (pT1 node negative), whereas cancers were frequently 'late stage' (more than pT2) and inoperable in nonattenders (44%) and controls (36%).",2396,2656,True
4005035,12867,significantly increase,A reliable and clinically significant improvement in depression scores was seen in 62.2% (n = 23/37) of those in the NetmumsHWD group at post-treatment compared with 29.4% (n = 10/34) of those in the TAU group. After adjustment for baseline EPDS the odds ratio for a reliable and clinically significant improvement in the treatment group compared with control was 0.26 (95% CI 0.10–0.71).,61341,61763,True
5827302,13365,significantly increase,Post-hoc analysis revealed a significant increase in SUDS in the exercise group after the intervention (Post-0= 3.8±0.8) compared to baseline (Baseline= 2.4±1.1; p=0.04) and after 10 minutes of resting (Post-10= 1.6±0.5; p = 0.003) (Fig. 2).,31667,31959,True
5545112,12778,significantly increase,"Vitamin D levels increased after ninety days of oral vitamin D3 in both treatment groups. However, the increase in vitamin D level in the 4,000 IU group of 16.8 ± 9.15 (p < 0.001) was significantly higher compared to the increase in the 2,000 IU group of 5.00  ±  3.82(p = 0.008).",26772,27100,True
1693922,13235,significantly increase,As indicated there were no significant differences between two groups after treatment except for social functioning (P = 0.03) and nausea and vomiting (P = 0.01) in the TCF group.,11677,11857,True
5066848,13027,significantly increase,"Improvement in lung function was greater in Japanese patients treated using IND/GLY compared with IND (90 mL), GLY (100 mL), TIO (90 mL), and placebo (280 mL; Figure 2).10 The spirometric profile in terms of trough FEV1 with IND/GLY was superior compared with TIO and placebo on Day 2 and Week 26, with treatment differences ranging from 90 mL to 290 mL (Figure 3).",14387,14916,True
3646683,11913,significantly increase,"The major difference in costs between the two groups was the cost for hospitalisation due to causes not related to MI, angina or chronic heart failure (p = 0.0043), resulting in higher hospitalisation ($6,841 vs. $4,984, p = 0.036) and total treatment cost ($10,574 versus $8,534, p = 0.021) for patients randomised to receive HC versus UC.",28854,29194,True
3646683,11913,significantly increase,There was no intervention effect measured using the SF-36/SF-6D and ProActive Heart resulted in significantly increased costs.,-1,-1,True
5519050,11935,no significant difference,"The median anti-GM-CSF measurement for all participants post-DNA doses was 0.242 mcg/ml, range from 0.156 to 2.762 mcg/ml, with no significant difference between active arm and placebo recipients.",56399,56595,True
1224861,11631,no significant difference,"Nor were there any significant differences between on-and off pump patients with regard to duration surgery (105 ± 22 vs. 80 ± 25, respectively, p = 0.26) or aortic cross-clamp time (21.5 ± 7.6 vs. 20.6 ± 7.5 min, respectively, p = 0.861).",13280,13536,True
5498709,12996,no significant difference,"There is no difference in hypotension between the two groups (p=0.17). The MAP changes were significantly higher in the C group only at the baseline (p<0.05). In addition, the lowest MAP belonged to the C group in the 35th-minute, and the highest MAP belonged at the baseline in this group. These changes were not statistically significant (Figure 1).",14688,15091,True
5498709,12996,no significant difference,"In addition, the lowest heart rate belonged to the C group in the third-minute, and the highest heart rate belonged to the M group in the 15th-minute. These changes were not statistically significant (Figure 2).",16010,16273,True
4914313,13408,no significant difference,"After a median follow-up of 61.2 months, no differences in median PFS from randomization were observed between arm A [median 7.6 months (95%CI: 5.1 - 10.3)] and arm B [median 9.5 months (95%CI: 4.1 - 15.0)]. RT = radiotherapy, FLUO: Fluoropyrimidine and CETUX = cetuximab.",16676,16949,True
1693563,11418,no significant difference,"The increase in HR and Ve occurred slightly later, and peaked within the first 40–60 seconds after adenosine injection.",14719,14839,True
1693563,11418,no significant difference,"there was a rapid development of dyspnea as signified visually on a modified Borg scale, and a significant (p < 0.05) tachycardia in each subject (Asthmatics +18%, Normals + 34%),",3921,4100,True
3525331,13139,significantly increase,"there was significant difference in the proportion of patients with a reduction of migraine days by at least 50% between the CXDT-HFG group and the placebo group at follow-up period (83.7% versus 64.3%, P = 0.014) (Table 1; Figure 2).",25927,26258,True
3525331,13139,significantly increase,"the mean reduction of migraine days in the CXDT-HFG group were 3.04 days, compared with 2.20 days in the placebo group at 12 weeks (95% CI, −4.13 to −1.93 versus 95% CI, −3.74 to −0.66; P = 0.033), and a mean reduction of 3.42 days in the CXDT-HFG group compared with 2.44 days in the placebo group at follow-up period (95% CI, −4.49 to −2.34 versus 95% CI, −3.97 to −0.90; P = 0.042).",25497,25916,True
5951872,13160,no significant difference,"No significant differences between the trial arms were found in emotional impact of the disease (19% vs 14%, p = 0.27) in endometrial cancer, or low trust that the treatment would help to cure the illness (16% vs 14%, p = 0.60) in ovarian cancer.",37654,37935,True
3781990,13083,no significant difference,PSA progression within the first four weeks was observed in 41% in the control group compared to 38% in the pomegranate group (p=0.83).,20736,20872,True
3781990,13083,no significant difference,"In conclusion, pomegranate beverage had no significant impact on PSA progression in patients with recurrent and advanced prostate cancer when compared to placebo.",30585,30747,True
1794254,11233,no significant difference,"At the end of the study, there was no difference between URO and placebo (fig. 2).",14240,14361,True
1794254,11233,no significant difference,There was no significant difference in changes in these variables between URO and placebo infusions.,16632,16733,True
4393831,11951,no significant difference,Hematuria occurred in one patient in the anticoagulant-alone group and in 2 patients in the thrombolytic-plus-anticoagulant group. The mean duration of hospital stay was 7.5 ± 1.5days in both groups.,23961,24160,True
5777928,12970,no significant difference,EDOF was significantly better than AOMF and AOP for HCVA averaged across distances (p ≤ 0.038); significantly worse than AOMF for LCVA (p = 0.021) and significantly worse than AOMF for CS in medium and high add-groups (p = 0.006). None of these differences were clinically significant (≤2 letters).,5658,6008,True
5827475,12476,significantly increase,PLMA had significantly higher expired tidal volume inflexion compared to I-Gel™ (P = 0.0017) [Table 2]. Significantly greater percentage decrease in expired tidal volume was seen with I-Gel™ compared to PLMA (38.6% vs. 23.6%) during flexion (P = 0.001).,16536,16862,True
1936359,11349,significantly decreased,"After 6 months of treatment significantly less (3%) patients treated with Azacytidine transformed to AML when compared to those in the supportive care arm (3% vs 24%, p<0.0001).",35596,35773,True
3269419,13184,no significant difference,"By contrast, artesunate seemed as effective when combined with chloroquine as it was when combined with SP (MH-OR = 1.04, P = 0.83).",67430,67564,True
3269419,13184,no significant difference,artesunate was more effective at preventing development of patent gametocytaemia than in clearing existing gametocytaemia.,67586,67709,True
1166569,11256,significantly increase,"Leg-press maximal strength increased by 64% after three months of training (pre: 48 ± 16 kg vs. post: 78 ± 27 kg, p < 0.05).",9532,9656,True
5735483,12675,significantly increase,"A study of the motor block, however, revealed that motor recovery took 177 ± 56.9 min in the bupivacaine group as compared to 236 ± 60 and 234 ± 61.71 min in the buprenorphine and dexmedetomidine groups, respectively.",21917,22135,True
4497726,12254,significantly increase,In PP analyses Visuospatial Processing and Simple Attention improved with 6-months of any exercise.,45546,45645,True
4497726,12254,significantly increase,"Visuospatial Processing improved in a dose-response like function across the four doses of exercise, although the 75min/wk and 150min/wk groups were similar (ΔX2 = 18.0).",45966,46147,True
3629990,12857,no significant difference,Only the variable herd was significantly associated with ulcer size on day 1 (Table  3). This implies that the size of the ulcer on day 1 did not differ between the two treatment groups nor was there an association with body condition or parity (Table  3).,26990,27324,True
4666408,12871,significantly decreased,Significantly reduced cardiovascular mortality could be seen in those on selenium and coenzyme Q10 intervention. A multivariate Cox regression analysis demonstrated a reduced cardiovascular mortality risk in the active treatment group (HR: 0.51; 95%CI 0.36–0.74; P = 0.0003).,5258,5533,True
5852975,11972,significantly increase,"The total mean score was significantly higher in the SM group (p = 0.04). In addition, mean scores for all seven empowering outcomes were higher in the SM group vs. the control group (Table 6).",36363,36615,True
5852975,11972,significantly increase,"There was a strong, positive correlation between empowering outcome total and SOC (r = 0.77; p = 0.005)",37082,37219,True
5769198,12115,significantly increase,"Environmental health scores showed the nonsignificant change between groups after 5 years (P = 0.240). There were significant improvement within YLSP group (5.07%, P = 0.044) and nonsignificant change in CLSP group (0.73%, P = 0.907) after 5 years.",20752,21051,True
4707401,11930,no significant difference,"All intubations in both groups were performed within 120 seconds, with no significant differences between groups regarding the rate of successful intubation of the trachea from first attempt (p=0.524, Table 2).",19598,19877,True
5758845,13247,significantly increase,"In the within-group analysis, change in SJDBT group and placebo group showed significant difference (p < 0.001 and p = 0.011, SJDBT group and placebo group, resp.).",19583,19785,True
5758845,13247,significantly increase,Anorexia and quality of life measured by FAACT and VAS were improved after 4 weeks of Sipjeondaebo-tang treatment.,-1,-1,True
3643134,12491,significantly increase,Twelve students (100%) in the simulator group were able to identify the basic instruments for the procedure compared with only 3 of 13 in the control group of students (23%).,11656,11830,True
3702133,12010,significantly decreased,There was significant decrease in percent lymphocyte count (P < 0.05) and increase in percent neutrophil count (P < 0.05) of treated group as compared to control.,18400,18604,True
4920563,11799,no significant difference,"When study and control groups were compared, a statistically significant difference was detected between ∆% 1st hour and ∆% 5th hour values of total and free PSA (p<0.05). However, there weren’t any significant differences between ∆% 24th hour and ∆% 72th hour values (p>0.05).",16357,16682,True
5771543,13181,significantly increase,"At week 8, the CGI-I response rate for fluoxetine (78.2%) was significantly greater compared with placebo (62.6%; p = 0.017).",34350,34492,True
1131903,11543,no significant difference,The number of questionnaires scored was 78 and equal in the two groups.,16043,16114,True
1131903,11543,no significant difference,No difference in mean score was found between the two groups (p = 0.65).,3752,3824,True
5781293,12179,no significant difference,NDII scores (p = 0.089) and CMAP amplitudes (p = 0.067) between the groups did not reach statistical significance at 12 months.,9106,9269,True
1291385,11472,significantly increase,"Co-administration of dexamethasone and diclofenac K was significantly superior to diclofenac alone for the relief of pain (P < 0.05),",-1,-1,True
4569055,12988,significantly increase,"Thirty-six students show no better progress (beginning and final test means = 69.87 and 80.98 points out of 176 for the control group, 64.60 and 78.11 for the CPOE group, p = 0.556) during their rotation in either group, even after adjusting for each student and CR, but show a better satisfaction with patient care and greater involvement in the medical team in the CPOE group (p = 0.035*).",8419,8811,True
5777928,12971,no significant difference,EDOF was significantly better than AOMF and AOP for HCVA averaged across distances (p ≤ 0.038); significantly worse than AOMF for LCVA (p = 0.021) and significantly worse than AOMF for CS in medium and high add-groups (p = 0.006). None of these differences were clinically significant (≤2 letters).,5658,6008,True
5838794,12271,no significant difference,"In contrast, treated participants in the WW condition lost more weight at 3 months than those in SG (−3.35 kg vs. −1.97 kg; F(1,125) = 4.96; P = 0.03), but there was no difference by condition at 6 months (P = 0.18).",33353,33620,True
5807505,12890,no significant difference,There was no statistical difference in performance [checklist vs. model—time (s): 445.5 vs. 496 p = 0.64—NOM: 437 vs. 413 p = 0.88 – PL [75]: 1317 vs. 1059 p = 0.32] or safety metrics [checklist vs. model—per: 0.5 vs. 0 p = 0.22—NCB: 0 vs. 0 p = 0.71—DVS: 0 vs. 0 p = 0.2] between the two groups (Fig. 5).Fig. 5,27414,27928,True
3531529,13359,significantly increase,"Inspiratory tidal volume of both groups did not differ over time; however, the expiratory tidal volume of the I-gel group at T1 was smaller than that of the PLMA group (P < 0.05).",14235,14415,True
5762805,12584,significantly decreased,revision thyroidectomy was necessary in 1 (0.6%) TT versus 5 (2.8%) DO versus 14 (8.0%) BST patients (p < 0.001).,5369,5502,True
5985578,12218,no significant difference,"Overall, there were no differences in TKR rates by treatment arm (LMWF-5A: 9/23, 39% vs. saline: 6/16, 38%, p = 0.92).",14892,15028,True
3658908,12031,no significant difference,"In both groups, all 16 subjects were grade O(no mucosal breaks) both before and after treatment(Table 2). There was no significant difference between Group O (from 0.6 ± 0.9 to 1.5 ± 1.1) and Group I (from 0.5 ± 1.1 to 0.9 ± 1.0) in the gastric Lanza score either before or after treatment (p = 0.20).",23471,23811,True
111183,11213,no significant difference,The PTEF increased both after albuterol and saline treatments but the difference between the two treatments was not significant. Both TEF10 and 25/PT significantly decreased after albuterol administration (P < 0.05). There were no significant changes in VPTEF/VEand tPTEF/tE either with albuterol or with saline (Table 3).,16551,17044,True
4920563,11798,no significant difference,"No significant changes in tPSA, fPSA, cPSA levels and f/tPSA values were found in control group (p=0.223, p=0.224, p=0.444, and p=0.718, respectively).",4515,4667,True
4920563,11798,no significant difference,"In control group, comparing to baseline levels tPSA, fPSA, and cPSA seemed to increase during the first hours and all PSA forms turned to basal levels after the 5th hour. But the magnitude of these changes was within the analytical CV’s of tests. Hence none of them were statistically significant (p=0.223, p=0.224, and p=0.444, respectively).",15996,16350,True
3626633,12466,no significant difference,Fat mass (kg),6931,6944,True
3626633,12466,no significant difference,"−2.4 ± 1.2
−1.7 ± 0.8
0.03
−2.8 ± 1.3
−1.8 ± 1.3
0.02",7164,7457,True
3655222,11855,significantly decreased,"The proportion of subjects needing additional uterotonic treatment was 3.1 % (95 % confidence interval (CI) 1.7–5.1 %) in the carbetocin group and 7.2 % (95 % CI 5.8–8.9 %) in all oxytocin groups combined, p = 0.0110 (Table 2). The relative risk for additional uterotonic treatment after carbetocin versus oxytocin was 0.41 (95 % CI 0.19–0.85).Table 2",17278,17716,True
3558645,11830,no significant difference,"In the condition of endotracheal intubation assessment, except for one case of a ""Poor"" in Group C, both groups were either Excellent or Good, and did not differ significantly (Table 3).",12083,12308,True
3544627,13191,significantly increase,"Post hoc testing revealed that in the fast condition, satiety was significantly higher at 5, 10, and 15min (p < 0.001) and tended to be lower at 60min (p = 0.017) compared with the slow condition, as shown in Figure 2C. AUC for satiety in the fast condition (4643 ± 175 mm·min) was marginally higher (t = 2.018, p = 0.053) than the slow condition (4315 ± 159 mm·min).",30675,31092,True
4173586,12295,significantly increase,"In the Group NP, 32% of patients desaturated [Table 2] against none in Group NC (P = 0.001).",14098,14246,True
2002515,11585,no significant difference,"For the primary outcome of a minimally important improvement in self-reported sleep quality (≥0.5 units on a 7 point scale), the difference between the valerian group (29%) and the placebo group (21%) was not statistically significant (difference 7.5%; 95% CI-0.9 to 15.9; p = 0.08).",6185,6468,True
1804280,11559,no significant difference,"There was no difference in mean HbA1c or BP levels,",6173,6225,True
1804280,11559,no significant difference,"The differences between intervention and control groups were not statistically significant. There were no differences between the two registers, so the adjusted values differ little from the unadjusted ones.",38220,38428,True
5986495,13202,significantly decreased,"Plasma ghrelin concentration, on the other hand, was significantly lower in SUC, as compared to WAT; this difference being significant at T = 30 min (t15 = −2.77; p < 0.05) and T = 60 min (t15 = −2.48; p < 0.05).",39290,39599,True
5668343,12975,no significant difference,"Hazard ratios for the treatment effect of letrozole versus tamoxifen were as follows—for disease-free survival: AIB1 low 0.85 (95% confidence interval 0.61–1.18) and AIB1 high 1.08 (95% confidence interval 0.76–1.54), and for overall survival: AIB1 low 0.91 (95% confidence interval 0.60–1.37) and AIB1 high 0.91 (95% confidence interval 0.60–1.41). No treatment effect heterogeneity was found between the AIB1-high and AIB1-low populations (Table 4; Fig. 3). Hence, these data indicate a similar benefit of letrozole versus tamoxifen regardless of AIB1 status.",46108,46749,True
4913995,13349,significantly increase,"The mean change in the score of sexual attitude in the intervention group (11.66±5.10) was significantly greater than in the control group (−0.42±3.03, P=0.0001).",24810,24991,True
4913995,13349,significantly increase,"The findings indicated that the most striking shifts for unfavorable attitudes were concerned with reduced sexual activity due to physical changes, lack of access to sexual pleasure without intercourse, and low sexual attractiveness.",24991,25224,True
3707921,13009,significantly increase,"Although both groups showed improvement in reducing the frequency of rule violation in the TOLDX, the mean reduction of the experimental group (−8.53) after the intervention was about four times that of the control group (−2.82), and the group difference was statistically significant with a large effect size (0.84), t(34) = 2.45, p = 0.019.",48910,49298,True
1618389,11429,no significant difference,"Mean response time for LMQs was 101 seconds (SD 32), compared with 107 seconds (SD 31) for OEQs, demonstrating no significant difference (p = 0.65).",17403,17602,True
3505775,12684,significantly decreased,"The mean TEWL from eczematous lesions on the flexor surface of the forearm for group A decreased significantly, compared to the baseline from 37.1±17.1 to 20.7±15.5 g/h/m2 (p<0.0001).",14593,14805,True
5866486,12626,significantly decreased,"There were no significant differences between the two groups at weeks 1 and 2, but significant differences were observed at weeks 3 and 4. The progress and improvement of DHI scores represent recovery and improvement in quality of life. In addition, the Romberg’s tests were improved in some patients who received vestibular rehabilitation.",20235,20575,True
5866486,12626,significantly decreased,The participants in the medical therapy and vestibular rehabilitation group had a higher change in functional and physical subtests.,22803,22936,True
1794491,11621,significantly increase,"The magnitude of PYY elevation was greater in patients during the 1 kcal/minute infusion (AUC: 441 ± 153 versus 186 ± 58 pmol/l.min, P < 0.05), but not the 2 kcal/minute infusion.",6065,6262,True
1779263,11354,significantly increase,"In addition, the intervention population showed significant improvements in two of the five investigated SF-36 scales at study end (vitality and mental health) compared to baseline scores, which for vitality was highly significant (p < 0.001).",35024,35267,True
5809707,11683,no significant difference,There was no difference in the time taken to achieve a PADS of 10 between group 1 and group 2 (P = 0.280).,15708,15815,True
5818021,12237,significantly decreased,"The risk of disability progression was significantly lower in patients treated with cladribine tablets 3.5 mg/kg (hazard ratio (HR) = 0.63, 95% confidence interval (CI) = 0.438, 0.894; p = 0.010) and 5.25 mg/kg (HR = 0.58, 95% CI = 0.406, 0.833; p = 0.003) than in those treated with placebo.",17686,18013,True
5850960,12699,no significant difference,"While the trial was not powered to detect difference in time to progression, as shown in Fig. 6a, there were no differences between study arms in terms of time to progression (median 161 days in Arm 1 vs. 164 days in Arm 2).",36076,36339,True
5865491,12447,significantly increase,The improvement in “on” time without troublesome dyskinesia was significantly greater with ER CD-LD versus IR CD-LD (Fig. 1B; ADVANCE-PD) and with ER CD-LD versus CLE (Fig. 1E; ASCEND-PD) in patients receiving a concomitant dopaminergic agonist. The increase in “on” time without troublesome dyskinesia with ER CD-LD in patients not taking a concomitant dopaminergic agonist was significantly greater only versus IR CD-LD (Fig. 1B).,17825,18369,True
5752804,12077,significantly increase,Total dose of rescue analgesia administered was much higher significantly in Group I (236 ± 106.44 mg) as compared to Group II (80 ± 69.98) (P < 0.001).,15242,15412,True
1074719,11488,no significant difference,"Median overall survival was 87 months for the cisplatin arm (82.0% at 3 years) and 89 months for the nihil arm (80.3% at 3 years) (p=0.66, log rank test).",15719,15873,True
1074719,11488,no significant difference,"There was no statistical difference between the two groups (p=0.41, log rank test).",16093,16177,True
1216327,11266,significantly increase,"The mean body weight gain was also higher among the juice fed patients; there was a mean weight gain of 18.3 gm in the AJ fed patients and of 50.6 gm in those given WGJ, whereas there was a mean loss of body weight (- 7.0 gm) among the WA group patients (p = 0.08).",25074,25339,True
1570354,11652,significantly increase,"Both SFC and FBC increased FEV1 at 16 hours post dose to a similar extent. The improvement from pre-dose baseline was 0.22 L for SFC and 0.25 L for FBC, which was statistically significant compared with placebo for both treatments (-0.05 L; p < 0.001) (Table 2).",17123,17438,True
2825665,12548,significantly decreased,Significant differences in favor of responders were also observed on the Dependence Scale (p=0.033).,5841,5958,True
2825665,12548,significantly decreased,"Antibody responders demonstrated a 17.6% lower mean score in caregiver dependence compared with placebo-treated patients (mean score ± SD of 10.2 ± 2.6 for placebo vs 8.4 ± 3.4 for antibody responders, p=0.033).",26333,26561,True
4169371,12143,no significant difference,"Overall, clinical improvement was 98.9% in ABLE group compared to 98.4% in LAmB group (p = 0.6414; 95% CI: −0.0248, 0.0359) (Table 2).",34951,35139,True
4372550,13149,significantly decreased,"In comparison with other two groups, the WEI JET reduced the number of tracheal intubation attempts, significantly, with significantly increased successful rate and decreased risk of hypoxia.",33657,33849,True
4372550,13149,significantly decreased,"There are still limitations in our study. First, our study is lack of a group which the WEI JET combined with direct laryngoscopy only, which means without lightwand. However, previous studies have demonstrated the advantages of WEI JET under direct laryngoscopy [23]. Second, observation bias may exist in the recordings for the unblinded design of this study. Third, all tracheal intubations were performed by an experienced anesthesiologist who is familiar with these techniques, therefore our results may not be suitable to inexperienced person.",35580,36184,True
3499458,12941,significantly increase,"Mean (sd) percentage of adherent days was 77.4% (26.3) in the intervention group and 69.0% (30.8) in standard care (mean difference between groups 8.4%, 95% confidence interval 0.2% to 16.7%, p = 0.044).",7027,7249,True
3499458,12941,significantly increase,"This well-specified, theory based intervention delivered in a single session of 30 min in primary care increased objectively measured medication adherence,",7380,7535,True
3544534,11794,significantly increase,"Elderly subjects expressed significantly higher health satisfaction in the TC group than in the PE group after 16 weeks (P = 0.036), and more subjects in the TC group recommended the program than did those in the PE group (Figures 3 and 4).",22121,22456,True
5773922,12852,no significant difference,"In this study, we have found that intake of krill oil, or lean and fatty fish do not significantly reduce serum TAG compared with a control in individuals with slightly elevated TAG.",72702,72885,True
1570354,11654,no significant difference,the median number of nights with no use of relief medication was also similar with 93% in the SFC group compared to 89% in the FBC group. There was no statistical difference between the groups regarding any of these parameters.,25478,25705,True
5816528,11759,significantly increase,The rate of canine retraction was significantly greater in the experimental side than in the control side in both groups by two-fold in the first month and 1.5-fold in the second month (p < 0.001).,6360,6574,True
1891198,11469,significantly increase,"Specifically, disease-free survival improved from 6 months to 13 months and overall survival improved from 28 months to 43 months in 126 randomized patients. Similarly, dexamethasone maintenance is also of benefit as shown in ncic ctg MY.7, which demonstrated a clear benefit in progression-free survival for patients receiving dexamethasone maintenance therapy after melphalan and prednisone18.",20590,21045,True
4236431,12285,significantly decreased,"tympanic membrane perforation persisted in 15.5% (95% CI, 7.3–27.4%) of the patients in the Dex group at the end of the observation period. On the other hand, no patient in the IGF-1 group showed residual perforation in the tympanic membrane. The difference in the incidence of tympanic membrane perforation was statistically significant (P = 0.001).",37974,38342,True
3544690,12681,significantly increase,"The walked distance in the six-minute walking test improved 75% in the electrostimulation group (from 379.7 ± 43.5 to 372.9 ± 46.9 meters to controls and from 372.9 ± 62.4 to 500 ± 68 meters to electrostimulation, p<0.001). On the other hand, the walked distance in the control group did not change.",6455,6754,True
3672758,12013,no significant difference,Cleaved caspase-3 and CD34 expression were not significantly different between the celecoxib-treated and placebo-treated groups.,8808,8936,True
3261693,12165,significantly decreased,"At both 1 and 3 months following cataract extraction, changes from preoperative levels of anterior chamber cells were significantly smaller in implanted eyes compared with non-implanted eyes, which still had increased levels of anterior chamber cells 3 months after cataract surgery.",21298,21581,True
3629990,12859,significantly decreased,"For lean sows with mats, the ulcer on day 21 was 3.4 cm2 versus 6.6 cm2 for lean sows which received antibiotic spray (P-value for difference =0.0001).",46287,46478,True
1134663,11876,no significant difference,"we found a significant shortening of the latency differences between the onset of the APB and deltoid muscle contraction during the course of the motor training as revealed by ANOVA for repeated measurements (significant influence of the factor ""training duration"", F(3.14,43.95) = 17.729, p < 0.001;",10980,11281,True
1134663,11876,no significant difference,"Memantine did not affect this training effect, as shown by the non-significant influence of the factor ""drug"" (F(1,14) = 1.876, p = 0.192), and by the non-significant interaction between both factors (F(3.14,43.95) = 1.646, p = 0.191).",11330,11566,True
88884,11183,significantly increase,Smokers have clean smelling clothes .............	90.0	94.5	p < 0.0001,32911,33050,True
88884,11183,significantly increase,Pooled analyses showed that short-term retention on most items was achieved.,-1,-1,True
5587887,13039,significantly increase,Internal consistency of the global satisfaction score was higher (P=.03) in the Internet group (Cronbach alpha estimate=.89; 95% CI 0.86-0.91) than in the telephone group (Cronbach alpha estimate=.84; 95% CI 0.79-0.87).,12812,13033,True
3668608,12928,significantly increase,"The mean difference between IPT and MoodGYM on the CES-D for completers at posttest was 1.92 points (95% CI –0.86 to 4.70, P=.17). MoodGYM participants scored nonsignificantly lower at posttest.",35566,35782,True
5852777,12318,significantly increase,A comparison of bacteria counts between the experimental groups after the three-month intervention revealed a significant increase (p < 0.05) in BIF count in the Synergy 1 group.,21324,21520,True
4706730,12576,no significant difference,"Results showed that the rate of success in double dose method was more than single dose one (79% versus 69%) but the difference was not significant (P = 0.29). Although the need for operation and extra dose of MTX were lower in the double dose group (15.8% vs. 18.8% and 5.26% vs. 13.2%, respectively), these differences were not significant too.",5242,5588,True
5698974,11890,significantly increase,"In order to compare the satisfaction with surgery results, a subjective questionnaire IKDC 2000 was used. In comparison of the scores from both groups, the mean scores for Endobutton and Rigidfix were 89 ± 4.3 and 85 ± 2.9 respectively and patients satisfaction in Endobutton was statistically higher than the Rigidfix group (P = 0.006).",16143,16498,True
5749033,12678,significantly increase,"The results revealed a significant increase in the size of the H-reflex after HIIT (P=0.004, d=0.77), while this remained unchanged in the control group (P=0.134, d=0.31).",26018,26189,True
3375426,13067,significantly decreased,"The median time until normalization of the serum CK level was significantly less in the GB-0998 group, at 22.0 days, than in the placebo group, in which it was 57.5 days (generalized Wilcoxon test, p = 0.0301).Fig. 4",34379,34634,True
60658,11399,no significant difference,"A higher risk for SGA was observed among the offspring of women who received a βb agent (OR 2.3, 95% CI 1.3–3.4), a non-βb agent (OR 2.1, 95% CI 1.3–3.4), or both (OR 2.7, 95% CI 1.8–3.9) (Table 4).",27606,27844,True
3493721,12545,significantly increase,"Accordingly, we believe that the monthly GMA should increase the long-term survival (without relapse) as indicated by the Kaplan-Meier survival analysis (p=0.0219, vs Sham; p=0.0439, vs Control).",19480,19677,True
1550875,11390,no significant difference,"There was also no difference between VFDs within 28 days after infection: the number of VFDs for each group was 16.1 ± 8.3 VFDs after C treatment, 12.6 ± 8.1 VFD after C-A treatment and 12.6 ± 10.4 VFD after C-L treatment (p > 0.05).",17368,17619,True
3505775,12683,significantly decreased,"In patients from group A who wore the anion textile garment, the mean SCORAD index decreased significantly from 47.2±14.0 to 36.1±16.5 (p<0.0001), compared to the baseline. In contrast, the mean SCORAD index of the subjects in group B, who wore the pure cotton textile garment, decreased only slightly from 41.8±16.3 to 37.7±17.2 (p=0.0839).",13138,13516,True
4161888,12281,no significant difference,"Renal outcome, i.e. independency of renal replacement therapy 28 days after initiation of CVVH in surviving patients, did not differ between groups: 29/43 (67%) in the citrate-treated patients versus 33/47 (70%) in heparin-treated patients (P = 0.82).",6902,7155,True
5457616,12134,significantly decreased,"BMI had significant differences at the end of study in PG and SG statistically (P = 0.012 and P = 0.054, respectively).",22591,22745,True
5457616,12134,significantly decreased,"Our findings also have been demonstrated significant decrease in BMI in SG, and weight and BMI increased significantly in PG at the end of the study.",37725,37874,True
529470,11423,significantly increase,"Using the time to azoospermia outcome, the difference between the two groups was also significant (p < 0.0001) (data not shown).",18911,19039,True
529470,11423,significantly increase,Life-table analyses of time to success showed that the participants in the cautery study reached severe oligozoospermia significantly more rapidly than did those in the fascial interposition study (p = 0.0049) (Figure 2).,18393,18652,True
4987981,13294,significantly increase,"Statistically significant improvement was observed in Psoriasis Area and Severity Index (PASI), Erythema, Scaling and Induration (ESI) and Physician global assessment (PGA) scores in pioglitazone (p values – PASI = 0.001, ESI = 0.002, PGA = 0.008) and metformin groups (p values – PASI = 0.001, ESI = 0.016, PGA = 0.012) as compared to placebo.",4000,4379,True
59604,11198,no significant difference,"However, the first outcome trial, ELITE II (Losartan Heart Failure Survival Study), did not show any significant difference between losartan and captopril in terms of mortality or morbidity.",2570,2761,True
4541705,12882,significantly decreased,"From polyp resection, the time required for wound surface treatment completion was 3.26 ± 1.57 min in the snare cauterization group and 12.7 ± 2.92 min in the clip closure group, thus demonstrating a significant difference (P = 0.0001).",21706,21961,True
59610,11167,no significant difference,"The authors of that report concluded that LMWHs have equal effectiveness to that of unfractionated heparin in the prevention of recurrent episodes of venous thromboembolism, and equal safety with respect to the occurrence of major bleeding.",10481,10723,True
1766476,11300,significantly decreased,"The difference in fall risk, expressed as time lapse to first fall, was compared between intervention and control groups in a Cox regression (HRR). Including all patients in the calculation, the fall risk was significantly lower in the intervention group, HRR 0.41 (95% CI: 0.20–0.82, p = 0.012).",31633,31946,True
5057363,12273,significantly decreased,"Treatment with atacicept was associated with greater median reductions from baseline to week 32 in the levels of IgG, IgM, and IgA (median change from baseline −31.2% [IQR −49.6, −24.1], −60.9% [IQR −71.88, −54.43]), and −56.4% [IQR −66.84, −45.49], respectively) compared to placebo (median change from baseline −4.4% [IQR −10.17, −1.32],",43954,44293,True
1693563,11417,no significant difference,"All subjects experienced an increase in respiratory sensation after the adenosine injection, represented by an increase in the Borg dyspnea score (Fig 1). The changes in Borg dyspnea score were evident within 20–40 seconds, which was also the time of peak intensity of the dyspnea; in verbalizing the sensation after intravenous adenosine, 9 subjects described ""chest tightness"", 7 subjects described the sensation as ""shortness of breath/difficulty in breathing"" and 3 subjects described constriction in the throat.",14165,14718,True
3661822,12228,significantly decreased,Gastrointestinal (GI) disturbance was the most common AE (41%) and was lower in the M + R group (P = 0.018).,3348,3474,True
3766084,11990,significantly increase,"This difference can be explained by the fact that, as compliance with the norm is a combination of the minutes of PA and the days of PA per week (minimum of 30 minutes a day, 5 days a week moderate to intensive PA), the Web-based basic intervention group performed significantly more days of PA per week at baseline than the control group (p = .000), the printed environmental group (p = .029) and the Web-based environmental intervention group (p = .010).",30593,31100,True
1891198,11471,significantly decreased,"Recent reports from the Southwest Oncology Group indicate that use of prednisone at a dose of 50 mg on alternate days significantly affects disease-free and overall survival after standard-dose chemotherapy, with minimal toxicity17. Specifically, disease-free survival improved from 6 months to 13 months and overall survival improved from 28 months to 43 months in 126 randomized patients. Similarly, dexamethasone maintenance is also of benefit as shown in ncic ctg MY.7, which demonstrated a clear benefit in progression-free survival for patients receiving dexamethasone maintenance therapy after melphalan and prednisone18.",20307,21044,True
3718763,12022,significantly decreased,"Compared with placebo, IPE 4 g/day significantly reduced TG, non-high-density lipoprotein cholesterol, very-low-density lipoprotein cholesterol (VLDL-C), lipoprotein-associated phospholipase A2, apolipoprotein B (Apo B), total cholesterol, high-density lipoprotein cholesterol, VLDL-TG, oxidized LDL, and remnant-like particle cholesterol in all 3 diabetes groups, LDL-C in the total diabetes group, and hsCRP in the total and less-controlled diabetes groups.",5539,6009,True
5812877,11845,no significant difference,there were no significant differences between and within hot and cool trials in salivary lysozyme concentration (p = 0.925; 4.79 ± 1.37 and 4.44 ± 1.11 μg/ml respectively) and secretion rate (p = 0.843; 1.67 ± 1.1 and 1.17 ± 1.0 μg/min respectively).,6209,6497,True
5791397,13363,no significant difference,No significant difference was found in terms of transurethral access no. between Group 1 and 2 (P = 0.643). Operative time was also similar in both groups (P = 0.428).,12633,12801,True
3698086,11917,significantly decreased,"Moreover TO decreased the percentage of elastic fibers in the alveolar walls of DH lungs (P = 0.004) to a comparable level to that of the SHAM lungs. Finally SHAM lungs subjected to TO showed an increased in the relative abundance of elastin-secondary crests (P = 0.013). TO also tended to reduce the percentage of elastic fiber within the alveolar walls, but differences with SHAM lungs were not significant (P = 0.161).",55869,56341,True
3936115,12277,significantly increase,"Subjective improvement in observed symptoms based on a single closed-end question (yes or no answer): “Did you observe adequate relief of diverticulosis related to abdominal pain or discomfort within the past 12 months?” was reported to be higher in the treatment group (55.67 vs 22.73 %, p = 0.0143).",18502,18820,True
3751553,12181,no significant difference,"There were no significant changes in bedtime, wake-up time or nocturnal sleep time during BL and BLF. However, bedtime and wake-up time were significantly delayed during Ramadan (p < 0.05), reflecting the delay in the start of work.",24240,24490,True
4601415,12831,significantly decreased,Their evaluation indicated that fractional CO2 laser treatment combined with punch elevation was more efficacious than fractional CO2 laser treatment alone at 4 months after treatment (P = 0.02; Table 2; Figures 1 and 2).,16030,16403,True
3505775,12685,no significant difference,A significant difference was detected in the mean TEWL from eczematous lesions between groups A and B (p=0.0359) (Fig. 3).,14963,15141,True
3505775,12685,no significant difference,And no significant difference was observed in the mean TEWL from perilesional normal skin between groups A and B (p=0.0822).,15141,15283,True
3611107,13239,no significant difference,There were no significant changes in systolic or diastolic blood pressure or pulse rate between groups during the study period (Table 4).,20363,20539,True
4173592,12378,significantly decreased,"when pre-induction SBP, DBP and MAP were compared with subsequent readings at 3, 5, 10, 15, 30, 45 and 60 min it was found that Group A and Group B were significantly different. There was a significant reduction in SBP, DBP and MAP in Group B at 3, 5, 10, 15, 30, 45 and 60 min (P < 0.01, P < 0.05, P < 0.01 respectively) [Tables 1-3 and Figures 1-3].",9557,10120,True
3483098,12046,significantly decreased,"Time spent with a sensor glucose level <3.9 mmol/l was significantly less during the Sensor On period compared with the Sensor Off period (19 vs 31 min/day, respectively; p = 0.009). In addition, significant differences in the average daily time spent in euglycaemia (3.9–10 mmol/l) and hyperglycaemia (>10 mmol/l) were observed in favour of the Sensor On arm (Table 2).",23580,24015,True
1847683,11454,significantly decreased,A dosage of 6 grams concentrated β-glucan per day for six weeks produced significant reduction from baseline in total and LDL cholesterol.,42270,42409,True
1847683,11454,significantly decreased,"Oat β-glucan produced significant reduction from baseline in total cholesterol (-0.3 ± 0.1 mmol/L) and LDL cholesterol (-0.3 ± 0.1 mmol/L), and the reduction in LDL cholesterol were significantly greater than in the control group (p = 0.03).",4912,5154,True
4132222,12721,significantly increase,"The CPA group showed a trend toward higher prevalence of lesion scabbing, a sign of healing, after 12 weeks of treatment (6.8%) than those treated with placebo (1.3%, P=0.09).",25295,25488,True
1764200,11458,significantly decreased,"When the groups' decrease of painscore on VAS was compared as a percentage, the Wilcoxon two-sample test yielded p = 0026 (Fig. 5).",13265,13433,True
1764200,11458,significantly decreased,"Six dogs given meloxicam and cephalexin showed an average decrease of pain on day 2 of 28.3%, whereas the 6 dogs given placebo and cephalexin showed an average decrease of pain on day 2 of 8.3%.",2460,2654,True
5438446,12298,no significant difference,"The relative risk of hospital admission for EDGE was 0.83 (0.56-1.24, P=.37) compared with usual care.",47584,47703,True
5438446,12298,no significant difference,"The EDGE clinical trial does not provide evidence for an effect on COPD-specific health status in comparison with usual care, despite uptake of the intervention.",-1,-1,True
2836470,11836,no significant difference,"In the eight-pulse arm, 59 out of 250 FVT episodes (22%) required one or more shocks (total shocks 72). In the 15-pulse arm, 45 out of 209 FVT episodes (21%) required one or more shocks (total shocks 50). No significant differences were observed between groups (p = 0.907).",27802,28092,True
5735450,13226,significantly decreased,Cuff pressure and volume achieved in the end of surgery were much higher in air group as compared to lignocaine group (P < 0.05).,4665,4814,True
5735450,13226,significantly decreased,"The mean cuff pressures obtained at the end of surgery were 49.86 cm H2O and 19.66 cm H2O in A and L group, respectively, proving statistically significant difference between the two groups",12740,12952,True
3621795,12813,significantly increase,"At the end of RT, the mean Se level was 90.9±19.9 μg/l in the SeG and 61.4±15.5 μg/l in the CG (p<0.001) (Table 2).",21787,21947,True
1891439,11580,significantly decreased,"Relapse rates were 12.4% (6/51) in the cefixime group and 3.4% (2/87) in gatifloxacin group (HR[95%CI] = 0.185 [0.037–0.915], p =  0.0199).",41968,42108,True
1891439,11580,significantly decreased,"Overall failures (acute treatment failure plus relapse plus death) were 29 in number (Figure 1). Overall failure rate at 1 month was estimated as 37.6% (95% CI = 27.14% – 50.2%) in the cefixime group and 3.5% ( 95% CI  = 2.2%–11.5%) in the Gatifloxacin group (HR[95%CI] = 0.084[ 0.025–0.280], p<0.0001) ( Figure 5)",42622,43043,True
4771973,11994,significantly decreased,"HbA1c level at end of trial was lower in the metformin group compared with the placebo group, p=0.006 (table 2).",48346,48528,True
5629746,12441,significantly increase,"In addition, the HFNC significantly improved the PaO2 and SpO2 at 24h after extubation compared to the air entrainment mask (83.2±10.5 mmHg vs. 74.5±13.1 mmHg, p=0.016; 98.0±1.3% vs. 96.9±1.4%, p=0.011, respectively).",17040,17348,True
3621795,12815,significantly decreased,The actuarial incidence of radiation-induced diarrhoea of at least CTC 2 in the SeG was 20.5% (8 of 39 patients) compared to 44.5% in the CG (18 of 42 patients) (p=0.04).,23539,23709,True
3643134,12490,significantly increase,"Compared with their peers in the study, students in the simulator group were significantly more likely to define the steps of cesarean section (91% vs 61.5%), and were comfortable in assisting cesarean section (100% vs 46.15%) as they were able to identify the layers of abdomen opened during cesarean section.",11345,11656,True
1866019,11600,significantly decreased,Relapse was defined as moderate-to-severe upper GI symptoms (a score of more than or equal to 3 on a 7-grade scale) for 3 days or more in any 7-day period. Esomeprazole was significantly more effective than placebo in maintaining relief of upper GI symptoms throughout 6 months of treatment.,5893,6186,True
5791469,11851,no significant difference,"the results came from Wilcoxon test indicated that mean score of variable of attitude of pregnant women regarding screening tests in group education after intervention was significantly greater than the preinvention phase (P = 0.001), but this difference was not statistically significant in face-to-face education and control groups (P = 0.09 and P = 0.40).",24551,24962,True
1868017,13049,significantly increase,"The results showed improvements in the intervention groups compared with the control groups, and they are supported by several previous intervention studies [5-8].",28492,28731,True
1868017,13049,significantly increase,"In men, the results showed significant differences in the changes between the intervention and control groups in depression (p = 0.017) and distress (p = 0.029)",5384,5544,True
1913555,11507,no significant difference,"Median GFR was not different between the two treatment groups at baseline (agalsidase alfa: 99 ml/min, range 22 to 136, agalsidase beta: 108, range 53 to 154, p = 0.50).",78580,78749,True
5788508,12457,significantly decreased,The highest systolic pressure drop after anesthesia induction occurred in group 5 (27±7 mmHg) and the lowest pressure drop belonged to the high dose fentanyl group (11±8 mmHg). A significant difference was observed in pressure drop among different groups (p<0.001). ANOVA test showed that the highest rise in systolic BP in the first minute following laryngoscopy and tracheal intubation occurred in group 5 which was the control group and the lowest rise occurred in the fentanyl group.,17087,17575,True
115849,11581,significantly decreased,"The most common reason for discontinuation was lack of efficacy, and significantly more patients discontinued due to lack of efficacy in the placebo group than in the etoricoxib and naproxen group (25.2%, 12.5%, 10.5%, respectively, p<0.001 vs placebo).",19517,19771,True
3669105,12598,no significant difference,"Myocardial T2* improved in both arms (combination +1.9 ± 1.6 ms p = 0.04; and DFO monotherapy +1.9 ± 1.4 ms p = 0.04), but with no significant difference between treatments (p = 0.65).",7837,8022,True
4173564,13091,significantly decreased,"Maximum rise in both the group was observed immediately after larygoscopy and intubation and these started to return toward the basal values at the end of the study period, but remained above the initial values. (pentazocine > nalbuphine P = <0.01).",4317,4590,True
4173564,13091,significantly decreased,"In group N, after an initial fall in mean RPP a clinically significant rise (+28.42%) was observed at IAETI which decreased to + 2.72% at the end of the study period. In group P, a continuous increase in the mean RPP above the basal value was observed throughout the study period maximum being at IAETI (+42.0%)",13306,13617,True
5781293,12177,significantly increase,"In the intention-to-treat analysis, mean ΔCMS results 12 months post-neck dissection were −6.82 (95% CI -9.47 to −4.17, σ = 7.02, SE = 1.70) and −25.13 (95% CI -32.73 to −17.53, σ = 20.15. SE = 5.04) points for the BES and NS groups, respectively (Fig. 3). Mann-Whitney U-test demonstrated a significantly higher CMS score in the BES group at 12 months indicating significantly better preservation of shoulder function compared to the NS group (p = 0.007) (Fig. 3).",29452,30012,True
3556286,12560,no significant difference,Independent t-test showed no significant differences in the average number of bacterial colonies before and after intervention in both groups (P>0.05).,4556,4741,True
3556286,12560,no significant difference,Green tea mouth rinse resulted in significant reduction of colony number of salivary S. mutans and Lactobacillus which is comparable with sodium fluoride mouth rinse.,5002,5202,True
3669033,12807,significantly decreased,"Salivary cortisol levels were significantly lower (−16% compared to placebo, PL) following tongkat ali (TA) supplementation (200 mg/day for 4 weeks). * = p < 0.05 by ANOVA.",21256,21429,True
3131514,12754,significantly decreased,"Peripheral glucose uptake was not reduced by prednisolone 7.5 mg, but was decreased by prednisolone 30 mg by 34 ± 6% (p < 0.0001).",5103,5251,True
3549293,11737,no significant difference,"Daytrip nor voucher intervention had an effect on the proportion of participants who returned all questionnaires (RD −0.01; 95% CI-0.07 – 0.06) and (RD 0.02; 95% CI-0.50 – 0.08), respectively.",5693,5885,True
3549293,11737,no significant difference,"The median percentage of all questionnaires received was 100 (IQR 75–100) in the daytrip group and 100 (IQR 75–100) in the control group. Median number of reminders sent was 2.5 in the daytrip group and 3 in the control group. The effect of the daytrip intervention on the percentage of all returned questionnaires and the number of reminders in the groups did not differ significantly (Wilcoxon P values 0.75 and 0.80, respectively).",36446,36880,True
4748323,11773,significantly increase,"Hand reaction time worsened significantly in the control group compared to the intervention group (F1,128 = 9.59, p = 0.002).",34460,34614,True
1852321,11665,no significant difference,"Improvement of hard stool consistency at intake to soft stool consistency after 3 weeks intervention was found more often with NF than SF, but did not reach statistical significance (90% versus 50%; RR, 1.8; 95% CI, 0.9 – 3.5; p = 0.14).",22357,22594,True
1977696,11450,significantly decreased,"The results show that a 60 Gy course produces a modest lengthening of progression-free and overall survival. They suggest a statistically significant prolongation of median survival from 9 months in the 45 Gy group to 12 months in the 60 Gy group (hazard ratio = 0.75, chi 2 = 7.36, d.f. = 1, P = 0.007).",1655,1960,True
3540956,13030,no significant difference,"the mean t1/2, volume of distribution (Vd) and clearance (CL) were not significantly different among the three doses (P > 0.05), suggesting that clearance was constant over that specific dose interval.",21664,21956,True
5866829,12783,significantly decreased,"Compared with the placebo group, the 5-, 10-, and 15-mg elobixibat groups showed significant decreases in LDL cholesterol from baseline levels after 14 days of treatment (t test; P = 0.0118, P < 0.001, P = 0.0067, respectively).",33437,33737,True
4644613,11730,significantly decreased,the cognitive performance recovery time in the Ketamine group was lower than that in the control group (P = 0.042).,5549,5665,True
2855831,11982,no significant difference,"The frequency of AEs in the active treatment groups was 17.8% (18 AEs in 18 patients), which was similar to that in the placebo.",29262,29391,True
57751,11285,significantly increase,Plasma creatinine rose by approximately 11% in those on active treatment. All of these effects were highly significant (P < 0.0001).,3793,3944,True
57751,11285,significantly increase,"Fig. 5a shows the expected rise in creatinine due to bezafibrate administration, initially approximately 13% and falling to 10% at 3 years.",34148,34324,True
101395,11609,no significant difference,The total amount excreted of codeine and its metabolites excreted was 81.3% of dose (76.3–86.3 95% CI) vs. 84.9% of dose (81.8–88.0 95% CI) and did not differ between the two treatment groups.,30670,30862,True
1550405,11318,no significant difference,"Results of normoovulatory patients and PCOS patients are shown separately in Tables 3 and 4. In both these subgroups, the only significant difference was the total FSH dose, lower when r-FSH was used (Tables 3 and 4). Although r-FSH showed a higher effectiveness in terms of delivery rates in both subgroups, it was not significantly different",24267,24766,True
1693563,11419,no significant difference,adenosine injection resulted in significant increases in Ve and heart rate in both groups (Figure 1).,13651,13790,True
3573541,12531,significantly decreased,"Significantly lesser number of women in the yoga group (n = 3) developed pregnancy-induced hypertension (PIH) / pre-eclampsia (PE) than those in the control group (n = 12), with absolute risk reduction (ARR) by 21%.",5075,5324,True
3691744,12211,significantly increase,"After 4 weeks of treatment, all doses of AZD3199 had increased mean peak and trough FEV1 values compared with placebo, but no clear dose–response was observed (Figure 2); peak FEV1 increased by 106–171 ml with AZD3199 treatment compared with placebo, while trough FEV1 increased by 97–110 ml (statistically significant at all dose levels).",28619,29028,True
3611103,11979,no significant difference,"the mean values of diastolic blood pressure (DBP) between measurements of the first reading and those of the second one were 80.7 ± 6.1 mm Hg in the sleeve group, 80.7 ± 6.1 mm Hg in the rolled sleeve group, and 80.6 ± 5.9 mm Hg in the bare arm group. These results indicate that there were no significant differences among the three groups (P = 0.77) (Table 3).",13285,13687,True
1388215,11641,significantly decreased,A follow up study 18 months post treatment showed that when using doxycycline alone there was a significant reduction of microfilarial (mf) loads in patients treated for either 4 or 6 weeks.,4985,5176,True
1388215,11641,significantly decreased,"Although no significant difference was demonstrated between the 4 and 6 weeks regimens, there was a trend observed, in that, microfilarial reduction appeared to have been greater following the 6 weeks regimen.",5288,5499,True
3563445,12822,significantly increase,"the supplementation with L. rhamnosus GG showed effects on three genus-like bacterial groups at the age of 18 months i.e. a year after the cessation of the probiotic supplementation. The children that had received L. rhamnosus GG had higher levels of the butyrate-producing groups Anaerostipes caccae et rel (LGG 2.89 ± 2.13% and placebo 1.18 ± 0.91% of the total microbiota, p=0.03) and Eubacterium ventriosum et rel (LGG 0.17 ± 0.11% and placebo 0.11 ± 0.07 of the total microbiota, p=0.04) than those of placebo group (Additional file 9).",36655,37322,True
2699720,11987,significantly decreased,"Weight loss occurred faster in the low-carbohydrate group than in the low-fat group (P = 0.005), but at 1 year a similar 3.4% weight reduction was seen in both dietary groups.",4900,5093,True
5388694,11896,significantly decreased,"The P2 latency analysis yielded a significant main effect of Test Time (F(2,196) = 4.6, p < 0.05, ηp2 = 0.05) and a significant interaction of Test Time × Group × Trial Type (F(4,196) = 2.42, p = 0.05, ηp2 = 0.05). Post hoc tests showed reduced P2 latencies at posttest compared to pretest, but only on single trials of the cognitive training group (p < 0.01; all other ps > 0.14, see Figure 3).",43698,44619,True
3606371,12095,significantly increase,The improvements were significantly greater among the ETN + MTX patients compared to DMARD + MTX patients for both physical (P = 0.003) and mental (P = 0.047) component summaries.,23435,23648,True
3769981,12768,significantly increase,A statistically significant increase in serum phosphate concentration was observed only for the paricalcitol 2-μg/day group at last on-treatment assessment (+0.29 mg/dL; P < 0.001 versus placebo).,22416,22613,True
4588995,13373,no significant difference,"Patient satisfaction was 8.3 for the closed capsule group compared to 8.5 for the control group. In comparing the two groups, there were no differences in magnitudes of score improvement for PRO measures, VAS, or satisfaction.",6501,6728,True
5777682,13106,significantly decreased,"When pain for the Lozenge group was measured as the mean pain score immediately before the next lozenge, pain was significantly lower in the Lozenge group than in the Control group for both the oral cavity (mean difference: −15 mm, 95% CI: −23 to −7, P = 0.0004) and the pharynx (mean difference: −11 mm, 95% CI: −22 to 0, P = 0.0452) (Table 2, Fig. 5).",28684,29147,True
4177075,12660,no significant difference,Analyses revealed no significant effect of group on the intention to use a cholesterol test (Table 3).Table 3,33924,34103,True
5207788,11901,significantly increase,"According to this analysis, patients in the CPM group were 2.2 times more likely to discontinue their treatment as compared to the MP group (HR = 2.21; 95% CI: 1.14–4.29), but they were 2.7 times more likely not to experience sustained EDSS progression (HR = 0.37; 95% CI: 0.17–0.84) (Fig 2).",43260,43604,True
60660,11193,no significant difference,"We did not observe significant differences of folate levels between UV exposed and non-exposed volunteers (P > 0.05).

Table 1",10547,10725,True
3483098,12048,significantly increase,"In addition, the number of temporary basal rates per day (0.75 ± 1.11 vs 0.26 ± 0.47; p < 0.0001), the daily use of the manual basal suspend function (0.91 ± 1.25 vs 0.70 ± 0.75; p < 0.018) and the bolus wizard calculator feature (3.82 ± 2.7 vs 3.14 ± 2.5; p < 0.0001) were significantly higher during the Sensor On than during the Sensor Off period.",28334,28744,True
1277845,11461,no significant difference,"Compared to the control trial postprandial insulinemia (dAUC) was lowered by 9% (P = 0.79), 16% (P = 0.54), and 19% (P = 0.20) for the 30, 60, and 90 min walking trials, respectively (Fig. 4).",16606,16836,True
3651308,11694,significantly increase,"there was a statistically significant difference seen in the IBS SSS for the website, with the no website group having a lower IBS SSS score than the website groups (IBS SSS no website =162.8 (95% CI 137.4-188.3), website 197.0 (172.4 - 221.7), Website + telephone support 208.0 (183.1-233.0) p = 0.037). This difference disappeared by 12 weeks (see Figure 2 and Tables 4 and 6).",52096,52591,True
5805693,12497,no significant difference,"For both meals, percentage of time <4.0 mmol/L did not differ between the adequate estimation and overestimation (0 [0–0] vs. 0 [0–0]% for both meals, p = 0.47 and p = 0.31 for the 75 g and 45 g meals, respectively).",15575,15791,True
3532036,12509,significantly increase,"Although disease-free survival was longer in the sorafenib group, this was not significantly different compared with the capecitabine group (χ2 = 2.444, P = 0.118). On the other hand, survival with disease (χ2 = 6.901, P = 0.009) and overall survival (χ2 = 7.154, P = 0.007) were significantly longer in the sorafenib group than in the capecitabine group.",13447,13886,True
5771543,13183,no significant difference,There were no statistically significant differences between desvenlafaxine or fluoxetine and placebo in the incidence of any prespecified TEAEs of clinical interest for desvenlafaxine (tier-1 TEAEs),41827,42026,True
4236282,11767,significantly decreased,LSD post-hoc analyses showed that post-treatment triglycerides in the NPC were significantly lower compared to UC (p=0.008) and trended towards significance for MIC (p=0.057).,25245,25454,True
3713945,12586,significantly increase,"Those who exercised in online teams (n=80) exercised significantly longer (time=78.8s, P<.001) than those who worked individually (n=35).",-1,-1,True
3665020,11839,significantly decreased,"On comparison between groups, only creatine kinase had a significant change at the end of the period (P = 0.03). However, in the intergroup comparison it was significantly decreased in group 1 (P = 0.002).",17319,17559,True
3665020,11839,significantly decreased,CK showed a significant increase 24 hours after the exercise in the placebo group.,20491,20574,True
3606616,11811,no significant difference,"There were no significant differences between the experimental and control group on the mothers’ score on the Breastfeeding Pain Scale administered before the screening, breastfeed session median 1.0 (Q1 = 1.0 – Q3 = 4.8) vs. median 1.0 (Q1 = 1.0 – Q3 = 4.0) p-value = 0.540.",56331,56650,True
1950208,11569,no significant difference,"As with the pattern for clinical malaria, the rebound in the risk of severe malaria starts immediately after discontinuing prophylaxis, but in this case is shorter, lasting for approximately 1 y.",30976,31172,True
1950208,11569,no significant difference,"Thereafter, there is a tendency for the risk of severe malaria to be lower in the chemosuppressed group, but the difference is not significant.",31172,31315,True
5850777,12616,significantly decreased,"Clinical (14.1% versus 16.8%) and ongoing (11.0% versus 12.4%) pregnancy rates and live birth rate (10.6% versus 11.7%) were similar in both groups (r-hFSH/r-hLH and r-hFSH, respectively), despite the biochemical pregnancy rate being lower with r-hFSH/r-hLH compared with r-hFSH (17.3% versus 23.9%; P = 0.020).",51163,51492,True
